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Proline is a unique and important amino acid. Proline is a proteogenic amino
acid and its metabolism is involved in many critical cellular functions. Therefore,
proline metabolism is tightly regulated, and dysfunction of proline metabolism is
related to human diseases. The first step of proline oxidization to ∆1-pyrroline-5carboxylic acid (P5C) is catalyzed by proline dehydrogenase (PRODH). P5C is
then non-enzymatically hydrolyzed to glutamate-γ-semialdehyde (GSA), which
can be further oxidized to glutamate by P5C dehydrogenase (P5CDH/GSALDH).
In Gram-negative bacteria, the PRODH and P5CDH enzymes are expressed as
one polypeptide called proline utilization A (PutA). In some Gram-negative bacteria
an additional ribbon-helix-helix (RHH) domain is at the N-terminus of PutA, thus
imparting additional DNA-binding activity.
The PutA RHH domain recognizes putC, which is the intergenic DNA between
the genes putP (encodes for a proline transporter) and putA (encodes for PutA).
Thus, the trifunctional PutAs regulate their own gene expression and proline
transport by sensing cellular proline levels. A linker region connecting the DNA
binding domain and the PRODH domain is believed to be important for PutA to
switch function from DNA binding to membrane binding. A detailed study of the
linker region in PutA from Escherchia coli is presented in Chapter 2.

Two natural thiol-containing proline analogs, the thiazolidine-2-carboxylic acid
(T2C) and thiazolidine-4-carboxylic acid (T4C), have been reported to have
beneficial and toxic effects in different organisms. In Chapter 3, T2C and T4C are
tested as substrates using the bifunctional PutA enzyme from Sinorhizobium
meliloti (SmPutA) as model for proline catabolic enzymes. X-ray crystal structures
of SmPutA in complex with thioproline analogs are available, making SmPutA ideal
for enzymatic characterization with thioprolines.
The PRODH and P5CDH/GSALDH domains are physically close to each other
in bifunctional PutAs, and tunnels have been found connecting both active sites,
allowing direct translocation of P5C/GSA from PRODH to P5CDH/GSALDH.
Chapter 4 presents kinetic characterization of SmPutA wild-type and site-specific
mutants, including a tunnel blocking mutant, and two monofunctional SmPutA
mutants that lack either PRODH or P5CDH/GSALDH activity.
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Chapter 1. Introduction
1.1 Proline metabolism and related enzymes

Figure 1. Proline metabolic pathway and enzymes. Adapted from “Role of proline
in pathogen and host interactions”19. Abbreviations: αKG for alpha ketoglutarate,
CoQ for coenzyme Q, CoQH2 for reduced CoQ, FAD for oxidized flavin, FADH2 for
2 electron reduced flavin, γGK for γ-glutamyl kinase, γGPR for γ-glutamyl
phosphate reductase, GLU for glutamate, GSA for glutamate- γ-semialdehyde,
NAD(P)+ for oxidized nicotinamide adenine dinucleotide (phosphate), NAD(P)H for
reduced nicotinamide adenine dinucleotide (phosphate), OAT for ornithine
aminotransferase, ORN for ornithine, P5C for ∆1-pyrroline-5-carboxylic acid,
P5CDH for pyrroline-5-carboxylic acid dehydrogenase or glutamate-gammasemialdehyde dehydrogenase, P5CS for P5C synthase, P5CR for P5C reductase,
PRO for proline, PRODH for proline dehydrogenase, and PutA for proline
utilization A.
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Proline is of special interest in different areas of study due to its roles in a variety
of important cellular functions among various species. Proline can be used as an
energy source1–3, and in some bacteria, proline can serve as the only carbon and
nitrogen source. Proline balances redox homeostasis4,5, response to stress6–11,
promotes pathogen virulence12–14 and, influences apoptotic15 and cell survival
pathways16. Proline has also proven to extend worm lifespan4 and affect
tumorigenesis in mammals17,18, and proline is one of the protein-building amino
acids.
Figure 1 shows the enzymes and reactions of the proline metabolic pathway.
The first step of proline biosynthesis is the phosphorylation of glutamate by ATPdependent γ-glutamyl kinase (γGK), which in bacteria such as Escherichia coli is
encoded by proB. The phosphorylated glutamate is then reduced to glutamate-γsemialdehyde (GSA) by NADPH-dependent γ-glutamyl phosphate reductase
(γGPR) encoded by the proA gene E. coli20,21. The γGK enzyme is negative
feedback regulated by proline22. In animals and plants, the reduction of glutamate
to GSA by γGK and γGPR is catalyzed by a single enzyme called P5C synthase
(P5CS)20,23. GSA spontaneously cyclizes to Δ1-pyrroline-5-carboxylate (P5C),
which is then reduced to proline by P5C reductase (P5CR or PYCR) using
NAD(P)H as the hydride donor. In some organisms, proline can alternatively be
synthesized from arginine via ornithine and ornithine aminotransferase (OAT)20.
The first step of proline oxidization is universally conserved through FADdependent proline dehydrogenase (PRODH)/proline oxidase (POX), which
converts proline to Δ1-pyrroline-5-carboxylic acid (P5C)24. In this reaction,
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electrons from proline are ultimately delivered to the electron transport chain to
generate reduced ubiquinone (QH2) (Figure 1). In prokaryotes, PRODH must
associate with the cytoplasmic membrane to catalyze proline oxidation and in
eukaryotes, PRODH is bound to the inner mitochondrial membrane. The hydrolysis
product of P5C, L-glutamate-γ-semialdehyde (GSAL) is further oxidized to
glutamate

by

L-glutamate-γ-semialdehyde

dehydrogenase

(GSALDH)

or

sometimes referred to as Δ1-pyrroline-5-carboxylic acid dehydrogenase (P5CDH),
which utilizes NADH as a cofactor24. Glutamate can enter the TCA cycle as αketoglutarate. At the same time, the intermediate P5C can be converted to
ornithine by ornithine aminotransferase (OAT)25. Therefore, proline metabolism is
linked to two critical pathways: the TCA cycle via glutamate and the urea cycle via
ornithine26.
1.2 Proline metabolism-related disorders
Proline metabolism is regulated by several enzymes and is directly connected
to critical cellular pathways as noted above and the pentose phosphate pathway.
Besides the aforementioned pathways, proline is critical for connective tissues and
is the building block of 4-hydroxyproline, the most abundant amino acid in collagen.
These factors along with proline oxidation and biosynthesis being localized in the
mitochondrion, are some of the underlying reasons why errors in proline
metabolism are related to various human diseases.
In humans, POX or PRODH is located at 22q11.2127, and GSALDH (P5CDH
or ALDH4A1) is at 1p3627. Deficiencies in PRODH and GSALDH lead to type I
hyperprolinemia28 and type II hyperprolinemia29, respectively. At least 16 missense
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PRODH mutations have been identified that lead to hyperprolinemia30. Evidence
suggests PRODH deficiency is linked to schizophrenia31–33, while type II
hyperprolinemia caused by P5CDH deficiency leads to vitamin B6 inactivation
resulting in seizures34,35. In addition to inborn errors, upregulation of proline
metabolism has been found in different cancers26,36, with down-regulation of
proline metabolism being shown to inhibit cancer cell growth and protein
synthesis37.

1.3 Proline utilization A

Figure 2. Domain architecture of PutAs. Adapted from “Structure and
characterization of a class 3B proline utilization A: Ligand-induced dimerization and
importance of the C-terminal domain for catalysis” by Korasick, David A.,
Thameesha T. Gamage, Shelbi Christgen, Kyle M. Stiers, Lesa J. Beamer, Michael
T. Henzl, Donald F. Becker, and John J. Tanner. Journal of Biological
Chemistry 292, no. 23 (2017): 9652-9665.
In Gram-negative bacteria, PRODH and P5CDH/GSALDH are transcribed as
the same polypeptide called proline utilization A (PutA). These bi-functional PutAs
are classified into type A or type B PutAs (see Figure 2) based on if there is an
additional aldehyde dehydrogenase superfamily domain at the C terminal38. PutA
from Sinorhizobium meliloti (SmPutA) has the best-resolved crystal structure
resolution of a type B PutA. Interestingly, in some Gram-negative bacteria such as
E. coli, there is an additional DNA binding domain at the N-terminal of PutAs that
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is responsible for regulating PutA expression (Figure 2). These tri-functional PutAs
are classified as type C PutAs38 with the best studied example being PutA from E.
coli (EcPutA). SmPutA and EcPutA, type B and C PutAs respectively, share 60%
sequence identity and 72% similarity (NCBI Blast). The major difference between
these two PutAs is the presence of the DNA-binding domain at the N-terminus of
EcPutA.
The expression of EcPutA is regulated by the proline utilization regulon (put
regulon) which contains two protein coding genes called putP and putA and one
regulatory region called putC. The putP gene encodes the high-affinity Na+/proline
transporter39, and putA encodes EcPutA itself. The N-terminal DNA binding
domain from EcPutA is a ribbon-helix-helix domain (RHH). The RHH domain
recognizes and binds to the intergenic putC region at five specific sites40. Under
proline deprived conditions, EcPutA suppresses the expression of both putP and
putA by binding to the putC region and preventing the initiation of the transcription41.
Upon accumulation of proline, putP and putA gene expression is upregulated as
EcPutA translocates from the DNA to the membrane. The reduction of the FAD
cofactor in the PRODH domain triggers a conformational change that favors
membrane binding of EcPutA42. The switching from DNA binding to membrane
association is referred to as functional switching. In addition to relieving repression
of the put genes, EcPutA-membrane binding is necessary for coupling proline
oxidation to reduction of ubiquinone in the electron transport chain (ETC) as noted
above43.
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A

B

Figure 3. Structure of EcPutA 86-669 active site with L-THFA bound (PDB 1TIW). (A) Front
and (B) side view of the flavin cofactor and surrounding active site residues. Adapted from
“Structures of the Escherichia coli PutA proline dehydrogenase domain in complex with
competitive inhibitors” by Min Zhang, Tommi A White, Jonathan P. Schuermann, Berevan
A. Baban, Donald F. Becker, and John J. Tanner. 2004, Biochemistry 43(39), 12539-48.
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EcPutA and SmPutA have been useful models to understand the mechanism
of proline oxidization. Even though the sequence similarity between the EcPutA
PRODH domain and human PRODH is only 20%, the similarity in active site
residues between the two proteins is 62%. The high sequence similarity in the
active site regions suggests a similar active site fold and catalytic mechanism
between human PRODH and EcPutA44.
The PRODH domain of EcPutA and SmPutA has a triose-phosphate isomerase
(TIM) barrel structure that consists of 8 β-sheets and 8 α-helices wrapping around
as a barrel. At the core of the barrel is the flavin adenine dinucleotide (FAD)
cofactor and the proline binding site45. Crystal structures of proline bound to the
PRODH active site are not available. However, crystal structures of EcPutA and
SmPutA in complex with the PRODH competitive inhibitor, L-tetrahydro-2-furoic
acid (L-THFA), have provided key insights into the proline binding site and reaction
mechanism. Figure 3 (panel A) shows L-THFA complexed to the PRODH active
site of EcPutA. Proline is thought to bind in a similar manner near the FAD enabling
hydride transfer from the C5 atom of proline to the N5 of the FAD (Figure 3A). A
structure was also solved with propargylglycine covalently linked to the N5 of FAD
(not shown). This covalent modification mimics the reduced FAD conformation
which involves a significant butterfly bend of the isoalloxazine ring and
conformational changes in the ribityl side chain of the FAD46. As shown in Figure
3A, Arg556 makes ion pair interactions with the ligand molecule. Mutation of
Arg556 (e.g., R556M) in EcPutA confirmed Arg556 has a critical role in catalysis
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and proline binding as the EcPutAR556M mutant is devoid of PRODH activity47.
The function of several residues near the active site has also been studied by sitespecific mutagenesis. For instance, a L432P mutant of EcPutA was made to study
the L441P polymorphism found in human PRODH. Mutation of Leu432 to Pro
significantly decreases EcPutA thermal stability by disrupting the interaction
around the hydrophobic core44 providing insights into the clinical observations of
the L441P mutant in patients (Figure 3B).

1.4 Enzyme allosteric effects
1.4.1 A brief history and introduction of enzyme allostery
Enzyme allostery refers to the regulation at another site that is distant from the
active site. Such phenomenon was first described in 1904 when Christian Bohr
observed that carbon dioxide affects the binding of oxygen to hemoglobin48.
Therefore it was called the Bohr effect until 1961 when the word “allosteric” was
coined to describe the non-steric mechanism of inhibition49.
The two well-accepted models of enzyme allostery are the concerted MonodWyman-Changeux (MWC)50 and sequential Koshland-Nemethy-Filmer (KNF)51
model. The concerted MWC model postulates that the subunits of an enzyme all
stay in one state, and that the change of state of one subunit, caused by the binding
of their substrates, will induce a state change to all other subunits. The sequential
KNF model, on the other hand, postulates that the change of state of the subunits
is not synchronized, that is, the state of all the subunits may not be the same. In
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1984, Cooper and Dryden presented an allostery model which takes the thermal
fluctuation or entropy effect into account and showed that a conformational change
is not required52. This theory was questioned three decades later by the Nussinov
group53 who did great contributions by pushing the allostery field forward. Nussinov
and his group published a series of papers that proposed a “conformational
selection and population shift” model which is been widely used to explain
allostery54–56. This model proposed there are “a range of conformations” rather
than just two known as the relaxed and tense states.
1.4.2 Methods for enzyme allostery studies
A powerful method for studying enzyme allostery is X-ray crystallography.
Crystal structures can provide structural information before and after allostery
takes place, which is the basis for understanding the force field around the protein
molecule. However, the dynamic information provided by crystallography is
limited57. NMR, on the other hand, is able to provide atomistic details on biological
macromolecules for timescale ranging from picoseconds to seconds58. Labeling
two different moieties of a protein within a certain range with fluorescent resonance
energy transfer (FRET) probes can monitor and calculate the distance in between
different conformational states, therefore, tracking the conformational change57.
Hydrogen Deuterium Exchange Mass Spectrometry (HDEMS) is another robust
method for allosteric effects. Combined with structural information, HDEMS can
map the protein-ligand interactions with high sensitivity59. Base on experimentally
reported motion, force field, and flexibility of residues and protein structures,
computational biology has become an increasingly helpful and reliable tool for
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simulating enzyme dynamics and providing visualization of gaps in experimental
data60.
1.4.3 Importance and applications of enzyme allostery
Understanding allostery mechanisms are important for understanding
biological processes and drug discovery. Allosteric effects are numerous in the cell
and include non-covalent mechanisms from ionic interactions, ligand binding,
assembly of multi-molecule complexes, to light absorption, and covalent
mechanisms such as post-translational regulation61. Hemoglobin is a well-known
example of allosteric regulation by ligand binding. The switch between the R
(relaxed) and T (tense) states of hemoglobin is triggered by pH changes and
binding and release of the oxygen molecule62,63. The histidine residue (146ß) in
hemoglobin is one of the modulators for the observed allosteric effect64. Allosteric
regulation is not limited to the protein level, but can be expanded to cell signaling65.
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Figure 4 Relative velocity of enzymes that obey Michaelis-Menten kinetics and enzymes that
exhibit allosteric velocity. Adapted from Essentials of Biochemistry (For Medical Students) (p20),
by B.S. Nayak, 2013, Jaypee Brothers Medical Publishers (P) Ltd.

The distance between allosteric binding sites and substrate binding sites can
vary66. Main types of allostery regulation include homotropic regulation and
heterotropic regulation. If the effector is also the substrate of the enzyme, then it
is called a homotropic allosteric effector, otherwise, it is a heterotropic allosteric
effector67. The kinetics of allosteric enzyme catalytic rate does not follow MichaelisMenten curve68 but shows a sigmoidal increase of velocity with the increase of
substrate concentration (Figure 5).

12

Figure 5. The rearrangement of chorismic acid to prephenic acid by chorismate mutase.
Adapted from “Allosteric Regulation of Catalytic Activity: Escherichia coli Aspartate
Transcarbamoylase versus Yeast Chorismate Mutase” by K. Helmstaedt, S. Krappmann,
and G. H. Braus, 2001, Microbiology and Molecular Biology Reviews, 65 (3), p. 404-421.
Copyright 2001 by the American Society for Microbiology.

Chorismate mutase (CM) is a well-characterized and the smallest model of
enzyme allosteric regulation which is in its oligomerization state and can be either
activated or inhibited by homotropic and heterotropic allosteric effectors,
respectively69. CM rearranges chorismic acid to prephenic acid (Figure 6). In
prokaryotes, CM is fused to prephenate dehydratase (P-protein) which yields
phenylalanine, to prephenate dehydrogenase (T-protein) to yield tyrosine, or to
phosphate synthase70. While in eukaryotes, the reported CM are found to be
monofunctional69. Interestingly, the structural and functional set up of
PRODH/P5CDH is similar to that of CM, with PRODH and P5CDH fused together
as a bifunctional enzyme in prokaryotes and as separate enzymes in eukaryotes.
Formylglycinamideribonucleotide amidotransferase (PurL) is another good
allosteric enzyme example. The bifunctional PurL is recently discovered to be able
to form a transient tunnel between the two active sites to transfer the intermediate71.
In PurL, the at loop at the N-terminal domain adopts defined secondary structure
upon the binding of substrate and acts as a cap covering one of the active sites,
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the formylglycinamidine synthetase site71. Such conformational change could also
be possible upon the binding of proline to PutA which would facilitate the catalytic
activity of either one or both active sites.
The fact that allostery is so prevalent in the cell suggests the study and
discovery of allosteric modulators will bring great potential for clinical application.
The famous inhibitor of rapamycin is an allosteric inhibitor for both mammalian
targets of rapamycin (mTOR) and the proteasome72. The first allosteric drug
approved by FDA was in 2004, and allosteric modulation has become an emerging
strategy for therapeutic development and drug discovery57,73. An allosteric drug for
the most recent pandemic caused by coronavirus 19 has been proposed and is
currently under clinical trial studies74,75.
1.4.4. Allostery in PutA

Figure 6. RHH (ribbon-helix-helix structure) is a typical DNA binding protein
domain. L1 (linker 1) is connecting the RHH and PRODH domain in wild-type
EcPutA. CTD (C-terminal domain) has critical role in membrane association. The
Δ50-85 EcPutA mutant lacks L1.
One focus of my thesis project is to explore the role of the linker region in the
functional switching mechanism of EcPutA (Chapter 2). The linker region includes
residues 50-85 and connects the DNA and PRODH domains of EcPutA (Figure 6).
The function of the linker region is unknown but previously it was postulated to be
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critical for the functional switching mechanism of EcPutA76. It may be that the linker
region is important for communicating redox signals from the PRODH domain to
the DNA binding domain.
Allostery in EcPutA involves communication from the FAD binding site to the
membrane-binding domain77. The membrane-binding domain involves the α–
domain near the PRODH active site and C-terminal residues 1309-132077.
Although far apart in sequence, these regions of EcPutA are postulated to form a
membrane-binding surface in the three-dimensional structure of the enzyme77.
Reduction of the FAD cofactor initiates allosteric effects that are relayed out from
the FAD through the PRODH domain resulting in activation of membrane binding.
The communication pathway is not known, however, a residue on a loop in the
active site have been shown to be critical for redox communication78,79. These
include residues Asp370, Glu372, and Glu373 of EcPutA PRODH domain which
are highly conserved in PRODHs (see Figure 3)79. Mutation of these residues
abrogates proline induced functional switching of EcPutA79.
Linker regions between functional domains in enzymes can have a critical role
in enabling protein dynamics that are necessary for function80–82. In a previous
study the DNA binding domain of EcPutA (RHH) was fused to the N-terminus of a
type 2 bifunctional PutA (RcPutA from Rhodobacter capsulatus) without a linker76.
The resulting EcRHH-RcPutA chimera exhibited DNA binding, PRODH and
P5CDH activities and lipid binding was induced by proline76. Whether the EcRHHRcPutA chimera could regulate the put regulon in cells was not examined. A major
focus of my thesis project is to examine the impact of deleting the linker segment

15
in EcPutA to determine the functional role of the linker in redox allostery and
functional switching. This work is described in Chapter 2.
1.5 Enzyme promiscuity
Enzymes are well known for their substrate specificity. Counter-intuitively, it is
not uncommon to see enzymes catalyzing more than one reaction. Such a
phenomenon is called enzyme promiscuity. Contribution to enzyme promiscuity
includes evolution, hydrophobic interactions, the reactive potential of active sites,
post-translational modifications, reaction condition, (e.g. pH, temperature, and
media), diverse enzyme conformations, alternative cofactors or residues,
structural similarity of the substrates, side reaction of the catalysis, and accidental
mutations83–85. From the evolutionary perspective, the organism benefits from
promiscuous enzymes86. In general, the side reaction of the promiscuous enzymes
is generally a few magnitudes lower than their main reaction87. However, over the
course of evolution, under the selection pressure, the side reaction of some of
those enzymes evolved to be their main reaction84. Understanding the mechanism
of enzyme promiscuity will expand our knowledge on cell signaling pathways and
have great potential in the biotechnology field especially for protein engineering88.
Enzymes distinguish their substrates by the substrate properties, therefore,
studying the kinetics of substrate analogs can identify new substrates or inhibitors.
Moreover, the screening of natural analogues may lead to the discovery of new
cellular functions of an enzyme.
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1.6 Natural proline analogues and potential applications
As previously described, proline is involved in several cellular functions and is
a protein-building amino acid. Proline also plays a critical role in proteins by
disrupting α–helix secondary structure otherwise known as an α–helix breaker.
Besides understanding the numerous biological roles of proline, there is also
significant research on natural occurring analogs of proline found in various
organisms such as bacteria, fungi, protozoans, plants, and humans. Some of the
proline analogs are precursors of antibiotics and mycotoxins89. A review paper by
Dr. Anthony Mauger (1996) summarized the source, stereochemistry, and function
of most known 5-member ring natural proline analogs with carbon-, nitrogen-,
oxygen-, and chlorine- substitutions known at that time89. Some typical prolineanalogs include trans- and cis- 4-hydroxyl-L-proline, trans and cis- 3-hydroxy-Lproline, α-methyl- and α-benzyl-L-proline, and L-azetidine-2-cartboxylic acid90.

Figure 7. Structures of three proline analogues of thiazolidine-2-carboxylic acid (T2C),
thiazolidine-4-carboxylic acid (T4C) and 1,3-dithiolane-2-carboxylic acid (D2C).
Recently, 1,3-dithiolane-2-carboxylic acid (D2C) (Figure 7) was found to be
photoactivated and reduce the bound flavin. For this thesis project we were
particularly interested in sulfur-containing natural proline analogs, namely L-
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thiazolidine-2-carboxylate (T2C) and L-thiazolidine-4-carboxylate (T4C) (Figure 7).
T2C is formed by the reaction of glyoxylate and cysteamine91. Thiazolidine-4carboxylic acid (T4C or thioproline) is the condensation product of L-cysteine and
formaldehyde. Both T2C and T4C are naturally occurring sulfur-containing proline
analogs with biological functions in a wide range of organisms (Figure 7). Under
minimal nutrient conditions, T2C and T4C supplementation showed partial or full
reversion of the growth profile of Colletotrichum trifolii92. T4C can serve as a
nutrient93–95 and antioxidant96 and scavenge free radicals, especially nitric
oxide97,98. In plants, T4C treatment showed improved seedling growth99 and
increased drought tolerance in peanut cultivars100.
T4C also possesses different therapeutic benefits in humans. For example, T4C
has been used to treat liver disease for several decades97; it can inhibit human
cancer cell growth101–103, reverse the transformation of advanced cancer104, and
prevent the development of aging-related disease atrial fibrillation105. An important
biological role of T4C appears to be as a storage molecule for L-cysteine, with Lcysteine being generated through the oxidative metabolism of L-T4C106.
Derivatives of L-T4C have also been shown to be involved in a variety of cellular
functions including working as a cytoprotective agent, biosynthesis of a copper
complex107, and inhibiting tyrosinase108. Despite many positive attributes, L-T4C is
also known for being toxic to cells. The main toxicity mechanism of L-T4C is
inhibition of protein synthesis by competitively binding to prolyl-tRNA synthetase
and being mis-incorporated into proteins109,110. Recently, a proline peptidase was
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shown to reverse L-T4C toxicity in E. coli by cleaving the thioproline incorporated
into proteins and releasing T4C to be then degraded via oxidative metabolism,
presumably by PutA111.
Previously, D-T2C was shown to be a substrate for the flavoenzyme D-amino
acid oxidase91. Recently, L-T2C was reported to covalently modify the flavin
cofactor of SmPutA112, renewing interest in this proline analog as a potential lead
compound for inhibition of PRODH in cancer cells. A focus of thesis project was to
examine proline catabolic enzymes in the metabolism of L-T2C and L-T4C.
Despite the important biological effects of these compounds and their therapeutic
potential, enzymological characterization of thioproline metabolism by proline
catabolic enzymes has not been reported. In this thesis SmPutA was used as a
model for exploring oxidative metabolism of thioproline by proline catabolic
enzymes PRODH and GSALDH. This work is described in Chapter 3.
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Chapter 2 The linker region is an allosteric regulator of proline utilization A
in Escherichia coli
Note: Most of the data reported here will be used to prepare for a manuscript. Lu
Zhang has contributed to the cell-based assays, and Benjamin W. Arentson has
prepared the pET21a-∆50-85 EcPutA and pUC18-∆50-85 EcPutA plasmids.

Abstract
The amino acid proline plays a number of roles in cellular functions; thus, the
proper regulation of its metabolism is critical. In Gram-negative bacteria, proline is
catabolized to glutamate by proline utilization A (PutA), a bifunctional enzyme
containing proline dehydrogenase (PRODH) and L-glutamate-γ-semialdehyde
dehydrogenase (GSALDH) domains. Some PutAs also contain a DNA binding
domain and are known as trifunctional PutAs, not only catalyzing proline
metabolism but also regulating the expression of the putA gene and the putP gene
encoding the proline transporter, PutP. A linker sequence between the DNA
binding domain and PRODH domain is shared in all trifunctional PutAs. In this
study, we explored the functional role of the linker in the trifunctional PutA from
Escherichia coli (EcPutA). An EcPutA variant lacking the linker (∆50-85 EcPutA)
was generated and characterized by steady-state kinetics, DNA-binding assays,
and cell-based activity assays. The oligomerization state, DNA binding ability and
PRODH activity of ∆50-85 EcPutA was similar to that of wild-type EcPutA. Cellbased assays showed ∆50-85 EcPutA was able to couple proline oxidation with
reduction of the cytoplasmic membrane and regulate a put reporter gene in
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response to proline. Unexpectedly, the GSALDH domain, which is far away from
the linker, displayed significantly lower activity both in vitro and in vivo. Altogether,
the results suggest that the linker region exhibits allosteric effects on GSALDH
activity.

Introduction
Proline has multifaceted roles in cellular metabolism, including critical roles in
cellular bioenergetics1–4, redox homeostasis5, stress response6, osmoprotection6–
8

, and bacterial pathogenesis9–12. The first step of proline catabolism is via proline

dehydrogenases (PRODH), which oxidizes proline to Δ1-pyrroline-5-carboxylate
(P5C)13. The P5C is non-enzymatically hydrolyzed to L-γ-glutamic semialdehyde
(GSAL), which can be further oxidized to L-glutamate by L-glutamate-γsemialdehyde dehydrogenase (GSALDH)13. In certain species, the PRODH is
transcribed together with GSALDH and the fused polypeptides are known as
proline utilization A (PutA)13 (see Figure 1).
An additional DNA binding domain is found at the N-terminus of PutAs from
some gram-negative bacteria, such as Escherichia coli, Pseudomonas putida,
Klebsiella aerogenes and Salmonella typhimurium14 (Figure 1). The DNA binding
domain from E. coli PutA (EcPutA) contains a typical ribbon-helix-helix domain
(RHH), the binding of which to the put regulon (putC) represses the expression of
putA and putP, the latter encodes the high-affinity Na+/proline transporter15,16. The
redox state of the PutA flavin cofactor controls whether PutA functions as an
enzyme or as a DNA-binding transcriptional regulator, a phenomenon known as
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functional switching17–19. When proline is absent, the bound flavin remains in the
oxidized state and PutA binds to putC; in the presence of proline, proline reduces
the flavin causing a global conformational change of the PutA, which induces PutA
binding to the cytoplasmic membrane. Once bound to the membrane, PutA
catalyzes the oxidation of proline by transferring electrons from reduced flavin to
ubiquinone in the electron transport chain20–23.
Multi-domain proteins are common among all species highlighting the many
physiological benefits of multiple functions in a single polypeptide24–26. Linkers,
generally 2 to 31 amino acids long, are a common structural feature in multidomain proteins and provide necessary flexibility, rigidity, and communication for
proper protein activities, especially for multi-domain proteins24,25. The DNA binding
and PRODH domains of the EcPutA are connected by a 35-amino acid linker
called L1. The structure and function of L1 is still unknown. Previous work has
characterized the function and structure of the RHH and PRODH domains,
however, a structure of full-length EcPutA that includes L1 has not yet been
solved1,27. To understand the functional role of the L1 linker, we created the linker
truncated EcPutA mutant, ∆50-85EcPutA, and characterized its enzymatic and
DNA-binding properties.
To characterize the functional role of the L1 region, we determined and
compared the kinetic parameters of ∆50-85 and WT EcPutA. We show here that
the ∆50-85 EcPutA has comparable DNA binding activity to that of WT EcPutA in
vivo and in vitro. The ∆50-85 EcPutA PRODH kinetics using different electron
acceptors are also similar to that of WT EcPutA. However, GSALDH activity is 5-
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fold lower and exhibits poor NADH production in cell-based assays relative to WT
EcPutA. These results are unexpected because the GSALDH catalytic domain is
far away from L1 and suggest that the L1 is an allosteric regulator of GSALDH in
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Figure 1. RHH (ribbon-helix-helix structure) is a typical DNA binding protein
domain. L1 (linker 1) is connecting the RHH and PRODH domain in wild-type
EcPutA. CTD (C-terminal domain) has critical role in membrane association. The
Δ50-85 EcPutA mutant lacks L1.

Material and Methods
All chemicals and reagents were purchased from Fisher Scientific, VWR, or
Sigma-Aldrich, unless otherwise specified. D,L-P5C was synthesized according to
the method of Williams and Frank and stored in 1 M HCl at 4 ˚C28 and its
concentrations were determined by measuring the formation of P5C and oaminobenzaldehyde (o-AB) complex at 443 nm (ε443 nm = 2590 M-1 cm-1)
strain

28.

JT31

(F-, lacZ1125, λ-, putA1::Tn5, trpA49(Am), relA1, rpsL150(strR), spoT1)

was a generous gift from J. Wood (University of Guelph, Guelph, ON). Membrane
vesicles were prepared as previously described29. The putC DNA region with a
fluorescent tag was amplified and purified as previously described21.
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Cloning of ∆50-85 EcPutA
The L1 linker was removed from EcPutA (EcPutA∆50-85) using the full-length
pET21a-EcPutA construct. First, PCR site-directed mutagenesis was used to
insert an EcoRI site at the codon for Asp48 in the pET21a-EcoRI construct using
primers:
(Fwd) 5’-CGAACAACTGGAAAACAGCGAATTCCTGCCGGAGC-3’
(Rev) 5’-GCTGTTTTCCAGTTGTTCGAGATAAGAAAAAATCGC-3’.
Next, a PCR product was generated with an EcoRI restriction site at the codon for
EcPutA Asp84 (EcoRI-Asp84) from the full-length pET21a-EcPutA construct using
primers:
(Fwd) 5’-CCATTCCTCGACTTTGCCGAGGAATTCTTGCCCCAGTCG-3’
(Rev) 5’-CGGCGCCTCGAGTTAACCTATAGTCATTAAGC-3’.
The pET21a-EcPutA (EcoRI-Asp48) construct was then cut with EcoRI and XhoI.
Following digestion, the pET21a vector coding for EcPutA residues 1-48 (EcPutA148) was gel purified. Next, the EcPutA (EcoRI-Asp84) PCR product was digested
with EcoRI and XhoI and ligated into pET21a-EcPutA1-48 using EcoRI and XhoI.
The EcoRI site in the resulting construct was removed with the following primers:
(Fwd) 5’-CGAACAACTGGAAAACAGCGACACCTTGCCCCAGTCGG-3’
(Rev) 5’-GCTGTTTTCCAGTTGTTCGAGATAAGAAAAAATCGC-3’
to make a seamless pET21a-EcPutA∆50-85 construct. The pET21a-EcPutA∆5085 construct was confirmed by sequencing the entire gene. The EcPutA ∆50-85
gene was then restriction cloned into pET15b using NdeI and BamHI and into
pUC19 using BamHI and XbaI (see appendix for plasmid map and sequence
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information) The pET15b-EcPutA∆50-85 construct was used for protein
purification and the pUC19-EcPutA∆50-85 construct was used for cell-based
experiments.
Overexpression and purification
WT EcPutA and ∆50-85 EcPutA were overexpressed in E. coli BL21(DE3) and
C43 strains using pET14b-WTEcPutA and pET15b-EcPutA∆50-85 expression
constructs, respectively. The WT EcPutA and ∆50-85 mutant were purified
similarly as previously described with minor modifications18. The cells were grown
in TB media and induced at OD600 around 0.8 with 0.5 mM IPTG at 18 °C for 16
hours. Cells were harvested and resuspended in 10 mL of Tris buffer (20 mM Tris,
500 mM NaCl, 10% glycerol, pH 7.6 at 4˚C) with 5 mM imidazole (IMD) per gram
of wet cell mass. Prior to cell lysis, TritonX-100 (0.2% final concentration), five
protease inhibitors (3 mM ε-Amino-N-Caproic Acid, 0.3 mM phenyl methyl sulfonyl
fluoride, 1.2 μM leupeptin hemisulfate, 48 μM N-tosyl-L-phenyl amine chloromethyl
ketone, 78 μM N-α-p-tosyl-L-Lysine chloromethyl ketone; final concentrations),
and 20 µM FAD (final concentration) were added to the cell suspension.
All subsequent purification steps were carried out on ice or at 4˚C. The
resuspended cells were lysed by sonication using a model 550 Sonic
Dismembrator (Fisher Scientific) using a amplitude setting of 5, for 5 min total
(pulse sequence of 5 s on and 15 s off). The cell lysate was centrifuged at 20,000
g using a JA 20 rotor for 30 min. The supernatant was collected, filtered through a
0.22 µm filter (Celltreat) before loading onto a Ni-NTA column. HisPur Ni-NTA
Superflow Agarose (Thermo Fisher Scientific) was packed in a borosilicate glass

34
column pre-equilibrated using Tris buffer with 5 mM IMD. The flow-through was
collected and loaded back onto the column again to maximize protein binding and
purification yield. The column was then washed with 5 mM IMD followed by
stepwise elution with Tris buffer containing 20, 40, and 250 mM IMD for WT EcPutA;
or 10, 40, and 250 mM IMD for ∆50-85 EcPutA. Elution fractions (2 mL) were
collected and analyzed by SDS-PAGE. Fractions with good yield and purity were
pooled and dialyzed into Tris buffer (20 mM Tris, 150 mM NaCl, 10% glycerol, 0.5
mM Tris(hydroxypropyl)phosphine (THPP), pH 7.6). The dialyzed protein was then
concentrated using an Amicon stir cell with 100-kDa molecular weight cut off
ultrafiltration disc (MilliporeSigma). Protein concentration was determined by the
Pierce assay and by UV-visible absorbance of the protein-bound flavin using the
extinction coefficient of 12700 mM-1cm-1 at 450 nm30. The N-terminal His-tag was
retained in the purified WT EcPutA and ∆50-85 EcPutA proteins.
Cell-based assay
JT31 lacZ- cells containing the pACYC-putC:lacZ reporter construct (low copy)
was used to test the transcriptional repressor activity of WT EcPutA and ∆50-85
EcPutA using the β-galactosidase activity assay as previously described15. In brief,
JT31 lacZ- (putC:lacZ) cells were transformed with pUC18-EcPutAWT, pUC19EcPutA∆50-85, and pUC18 empty vector. The cells were grown in M9 minimal
media (standard M9 media supplemented with 10 µM FeSO4, 0.005% L-tryptophan,
and

0.05%

thiamine

with

antibiotics

50

µg/mL

ampicillin,

34

µg/mL

chloramphenicol, 25 µg/mL kanamycin) with or without 15 mM proline and were
induced at OD600 0.2 with 0.25 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).
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Cells were harvest at OD600 around 0.8 and then lysed to measure β-galactosidase
activity. β-galactosidase activity assays with the cell lysates were conducted as
previously described31. β-galactosidase activity is reported in Miller Units, which
was calculated using equation 1, where t is the time (min) and v is the volume of
cells used (mL).
Miller Unit = 1000∗(Abs420−(1.75∗Abs550))/(t∗v∗Abs600) (1)
Gel mobility shift assay
The DNA-binding activity of ∆50-85 EcPutA was characterized using in vitro gel
shift assays performed similarly as previously described32. ∆50-85 EcPutA (0 – 4
µM) was incubated with 2 nM putC DNA (420 bp) containing a fluorescent tag
(IRdye-700 labeled at the 5’ end) and 200 µg/mL calf thymus DNA as a nonspecific
DNA control in 50 mM Tris-HCl, 10% glycerol, pH 7.5 for 20 min at room
temperature. The binding assay mixtures were loaded onto 4% native
polyacrylamide gel, which was run at a constant voltage of XX for X min at 4 ˚C to
separate the free and protein-bound DNA. The percentage of bound DNA was
quantified with ImageJ software and the binding constant was determined using
equation 2 where n is the number of binding sites (n=1 was fixed when fitting the
data) and [P] is total protein concentration.
Fraction of DNA bound = n[P]/(KD + [P]) (2)
Oligomerization determination
Sedimentation velocity experiments were conducted at 20 ˚C using a Beckman
XL-I analytical ultracentrifuge and An50Ti rotor as previously described33. ∆50-85
EcPutA (5 mg/mL) with or without 15 mM proline in Tris buffer (20 mM Tris, 150
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mM NaCl, pH 7.5) was loaded in a sedimentation velocity cell. Data was analyzed
using Sedfit34.
Steady-state PRODH and GSALDH kinetics
PRODH

activity

was

determined

by

using

DCPIP

(2,6-

Dichlorophenolindophenol) or CoQ1 (ε278 = 14.3 mM-1cm-1)35 as the electron
acceptor23,36,37. In brief, 0.1 µM enzyme was mixed with 75 µM DCPIP, 0.3 mM
phenazine methosulfate (PMS), and proline (0-600 mM) in 20 mM Tris-HCl, 10%
glycerol, pH 7.5 for the DCPIP assay. When using CoQ1 as the electron acceptor,
0.2 µM enzyme was mixed with 4 mM o-aminobenzaldehyde (o-AB) in 50 mM
potassium phosphate buffer (pH 7.5, 150 mM NaCl). In assays in which CoQ1 was
varied (0 – 250 µM), proline concentration was fixed at 40 mM. In assays varying
proline (0-200 mM) CoQ1 concentration was fixed at 0.2 mM. KM and kcat values
were obtained by fitting the initial rates to Michaelis-Menten equation using Prism38.
GSALDH assays were performed as previously described39. D,L-P5C stocks
were neutralized with 1 M Tris-HCL (pH 9.0) on the day of the assays. EcPutA
enzyme (2 µM) was mixed with 0.2 mM NAD+ and varied L-P5C (0 – 3000 µM) in
50 mM phosphate buffer (pH 7.5, 150 mM NaCl). Activity was monitored by
tracking the formation of NADH at 340 nm (ε340 = 6.22 mM-1cm-1 40). All kinetic data
plots and parameters are reported using L-P5C concentration, which is considered
to be half of D,L-P5C.
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Steady-state PRODH-GSALDH coupled activity assay
The PRODH-GSALDH coupled activity of EcPutA with L-proline was assayed
as previously described41. The reactions contained 0.25 µM WT EcPutA or ∆5085 EcPutA, 0.2 mM CoQ1, 0.2 mM NAD+, and 20 mM of L-proline in the assay
buffer (50 mM potassium phosphate, 25 mM NaCl, pH 7.5). The coupled activity
was measured by monitoring NADH production at 340 nm (ε340 =6.22 mM-1 cm-1).
Cell-based functional assays
To study functional membrane association in vitro, membrane vesicles were
used as electron acceptor as previously reported42–44. EcPutA enzyme (0.2 µM)
was mixed with 0.05 mg total protein/mL of membrane vesicles, 4 mM o-AB and
varied proline (0 – 250 mM) in 20 mM MOPS (pH 7.5, 10 mM MgCl2). The rate of
P5C-oAB complex formation was followed at 443 nm (2,590 m−1·cm−1 at 443 nm)45
and used to determine the initial velocity of the reaction.
Membrane association in vivo was tested as previously described by growing
cells harboring WT or ∆50-85 EcPutA on M9 minimal media agar plates with 2,3,5Triphenyl tetrazolium chloride (TTC), a indicator dye for reduction of the respiratory
chain in the cytoplasmic membrane
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. BL21 (DE3) putA- cells were transformed

with pET21a-WT EcPutA, pET21a-EcPutA ∆50-85, or pET21a empty vector. Cells
were cultured in LB broth (37 oC) until reaching OD600 of 0.5 and then streaked
onto M9 minimal plates containing 0.25% TTC, 0.5% glycerol or proline (weight to
volume). Cell plates were then grown at 37 oC until TTC reduction was evident (~
24 h).
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To monitor the kinetics of FAD reduction and NADH formation in whole cells,
BL21 (DE3) putA- cells containing pET21a-WT EcPutA or pET21a-EcPutA ∆50-85
were grown in LB broth to OD600 of 0.6 and induced with 0.5 mM IPTG for 3 h at
37 ˚C. The cells from 50 mL culture were then spun down and resuspended in 50
mM potassium phosphate (pH 7.5, 150 mM NaCl) to a final OD600 of 20. The
resuspended cells were then placed in a 5 mL Desa suspension presentation
chamber and placed in the OLIS CLARiTY. Proline (15 mM final concentration)
was then added to the cell mixture with continuous stirring and UV-visible
wavelength scans from 300 to 600 nm were collected at 1 min intervals for up to
20 min in the OLIS CLARiTY spectrophotomer. The absorbance changes at 450
nm and 340 nm represent FAD reduction and NADH formation, respectively.
Redox potential of ∆50-85 EcPutA
The redox potential of ∆50-85 EcPutA was determined using the
xanthine/xanthine oxidase method as previously described for WT EcPutA46. In
brief, 15 µM ∆50-85 EcPutA was mixed with 100 µM xanthine, 100 µM benzyl
viologen (mediator dye), and 100 µM resorufin (-79 mV, indicator dye) in potassium
phosphate buffer (10 % glycerol, 50 mM potassium phosphate, 150 mM NaCl, pH
7.5). The enzyme-dye solution was then degassed with 12 nitrogen-vacuum cycle
and transferred to an anaerobic chamber (Bell Technology Glovebox). Xanthine
oxidase (5 nM) was then added to initiate reduction of ∆50-85 EcPutA, which is
recorded using a Cary 100 UV-Vis spectrophotometer at 1 min intervals for up to
5 h. The ratio of (oxidized/reduced) dye and (oxidized/reduced) flavoprotein was
determined at different time points by following the absorbance at 570 nm and 450
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nm, respectively. The redox potential of ∆50-85 EcPutA was then determined by
fitting both protein and dye to equation 3 assuming the reaction reaches
equilibrium over the slow reducing procedure.
E = E!"#$%&" +

'.) +,
-.

/01213"2

log ( &"2%4"2 ) (3)

NAD+ binding study
NAD+ binding to WT EcPutA and ∆50-85 EcPutA was studied by monitoring
the intrinsic tryptophan fluorescence in the presence of NAD+ as reported
previously41. 0.25 µM WT or ∆50-85 EcPutA was mixed with varied
concentrations of NAD+ (0-120 µM) in 10 mM potassium phosphate (pH 7.5).
Maximum excitation and emission wavelengths of NAD+ were determined to be
290 nm and 335 nm. Therefore, the mixture was excited at 290 nm and emission
at 335 nm was recorded. The fluorescent signal was corrected using equation 4
and the KD was determined using equations 5 and 6.
F4/&& = F/5$ × 10(7!" 87!# )/' (4)
θ=

-[<7=$ ]%&!!
?' 8 [<7=$ ]%&!!

(5)

[NAD8 ]@&"" = [NAD8 ]A/A#B − θ[EcPutA]A/A#B (6)

Thermal shift assay and melting point temperature study
For thermal shift assays, WT or ∆50-85 EcPutA (2.5 µM) was mixed with 1 x
SYPRO orange dye (Bio-Rad), with or without 20 µM NAD+ in 25 µL PBS buffer
(pH = 7.4), which is known for its stable pH at different temperatures. The thermal
shift assays were performed using a Bio-Rad CFX Connect Real-Time PCR
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detection system, with a temperature range of 10-95 oC with 0.5 oC intervals, and
10 sec at each temperature. The Tm was calculated from Beamer Lab software47.
The stability of the WT and ∆50-85 EcPutA was also studied using circular
dichroism. The CD spectra of WT and ∆50-85 EcPutA (0.4 µM) in 10 mM
potassium phosphate with or without 4 µM NAD+ were monitored from 5 to 95 oC
with 5 oC intervals. The melting temperature was obtained by fitting the change of
absorbance at 222 nm versus temperature to a sigmoidal curve.
Statistical analysis
All assays were performed in technical triplicates, unless otherwise stated, and
experiments were conducted using different independent preparations of EcPutA
proteins.

Result
General properties
The L1 linker-truncated mutant (Δ50-85 EcPutA) (Figure 1) has a predicted
molecular weight of 143.55 kDa and purifies as a soluble protein. Purified ∆50-85
EcPutA has maxima absorbance peaks at 380 nm and 451 nm, similar to that of
WT EcPutA. The percent flavin bound was estimated to be ~50% for ∆50-85
EcPutA based on protein quantitation using the Pierce assay and the UV-visible
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spectrum of bound FAD (Figure 2). WT EcPutA typically purifies with 80-90%
bound FAD.

∆50-85 EcPutA spectrum
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Figure 2. Spectrum of purified ∆50-85 EcPutA. The spectrum shows a peak at
380 and 450 and a shoulder at 480 similar to the characteristics of a WT EcPutA
spectrum.
Oligomeric state and DNA binding
The RHH DNA-binding domain is responsible for the dimeric structure of WT
EcPutA. Here we determined the oligomeric structure of ∆50-85 EcPutA by
sedimentation velocity. Figure 3 shows ∆50-85 EcPutA exhibited a sedimentation
coefficient of ~ 9 which corresponds to a molecular weight of 309 kDa. This result
is within 10% of the predicted molecular weight of a dimer for ∆50-85 EcPutA (287
kDa). Addition of proline did not change the oligomerization state as observed by
sedimentation velocity (data not shown).
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Figure 3. Oligomerization state study of ∆50-85 EcPutA. (A) Size distribution plot
and sedimentation constant for ∆50-85 EcPutA (5 mg/mL). (B) Representative
radial absorbance profile at 450 nm as a function of time for ∆50-85 EcPutA at 5
mg/mL.
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Figure 4. DNA binding assays of Δ50-85 EcPutA. (A) Gel-mobility shift assay of
putC DNA with increasing concentration of Δ50-85 EcPutA. (B) A plot of the
fraction of bound DNA vs Δ50-85 EcPutA concentration. 5’-labeled (IRdye-700
label) putC region (419 bp) and varying concentrations of Δ50-85 EcPutA (0-1000
nM) was incubated in separate binding mixtures (50 mM Tris, 10% glycerol, 20 nM
IRdye-700, 200 μg/mL calf thymus DNA, pH 7.5) at room temperature for 20
minutes. The complexes were separated using 6% polyacrylamide native gel at
4 °C. The fraction bound are reported as the average from 10 replicates ± standard
deviation. The data were fit to equation 1 to yield an overall dissociation constant
of 187 ± 42 nM. (C) MST DNA binding assay using a fixed concentration of 5’IRdye-700-putC DNA and increasing concentration of Δ50-85 EcPutA.
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The DNA binding activity of EcPutA is dependent on the RHH domain, which
must be a dimer to bind the DNA. The observation that ∆50-85 EcPutA purifies as
a dimer indicates that the RHH domain is able to form a functional dimeric DNA
binding domain. The DNA binding activity of ∆50-85 EcPutA was first tested by
electrophoretic mobility shift assays (EMSA). Figure 4A shows that a protein-DNA
complex was formed with increasing concentration of ∆50-85 EcPutA. A plot of the
fraction of bound DNA vs ∆50-85 EcPutA concentration yielded a dissociation
constant (KD) for the protein-DNA complex of 187 ± 42 nM (Figure 4B), which is
four-fold higher compared to that of WT EcPutA (KD = 45 nM)48. To confirm the
result from EMSA, we also tested DNA binding using microscale thermophoresis
(MST). A serial 2-fold dilution of ∆50-85 EcPutA was mixed with a fixed
concentration of fluorescently labeled putC DNA. The change of the fluorescence
signal was recorded as function of ∆50-85 EcPutA concentration from which a KD
of 247 nM was determined (see Figure 4C). Thus, two independent experiments
confirmed that ∆50-85 EcPutA displays DNA binding activity.
PRODH activity and flavin redox potential
We next examined the PRODH kinetic activities since it is directly connected
to the L1 region. We tested PRODH activity using L-proline and three different
substrates as electron acceptors, DCPIP, CoQ1, and membrane vesicles. Proline
was varied while each electron acceptor was held at a fixed concentration. The KM
and kcat values for proline obtained with each electron acceptor are reported in
Table 1.
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Figure 5A shows the plot of initial velocity vs proline concentration for assays
using a fixed concentration of membrane vesicles. Overall, the kinetic parameters
for PRODH activity of ∆50-85 EcPutA are similar to that of WT EcPutA (Table 1).
The highest catalytic efficiency was observed using membrane vesicles as the
electron acceptor. The ability of ∆50-85 EcPutA to couple proline oxidation to
reduction of ubiquinone in the cytoplasmic membrane was confirmed by cell-based
assays in which reduction of TTC was monitored. Figure 5B shows cells
expressing WT EcPutA and ∆50-85 EcPutA both result in proline dependent
reduction of TTC whereas control cells containing the empty vector do not form
red colonies.
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Figure 5. Functional membrane activity assays. (A) Show the Michaelis-Menten
plot of your PRODH activity with membrane vesicles for ∆50-85 EcputA. This
would complement the cell-based data in panel B. (B) Cell-based functional
assays. BL21(DE3) putA- E. coli strain was transformed with pUC18 empty
vector, ∆50-85 EcputA-pUC18 or WT EcPutA-pUC18 gene. Cells were in LB
media and streaked on M9 agar plates containing 0.25% TTC indicator and
0.5% proline and grown overnight at 37 ˚C. The red colonies (formazan) indicate
the utilization of proline as a respiratory substrate and functional PutAmembrane interactions.

Table 1. Kinetic parameters of PRODH activity for ∆50-85 EcPutA and WT EcPutA
KM (mM)
kcat(s-1)
kcat/KM(M-1s-1)
Enzyme
Fixed substrate
Δ50-85 EcPutA
69 ± 11
19 ± 0.90
280 ± 59
DCPIPa
WT EcPutA
121 ± 30
18 ± 1.7
150 ± 51
Δ50-85EcPutA
62 ± 21
2.93 ± 0.37
47.4 ± 22.1
CoQ1a
b
b
WT EcPutA
47.5 ± 2.5
3.3 ± 0.5
70 ± 3.8b
Δ50-85 EcPutA
Membrane vesiclea
2.7 ± 0.5
1.05 ± 0.2
390 ± 160
WT EcPutA
1.5 ± 0.3b
0.43 ± 0.02b
287 ± 59b
Δ50-85EcPutA
0.072 ± 0.02
1.4 ± 0.12
20000 ± 5800
Prolinec
WT EcPutAa
0.11 ± 0.02
3.4 ± 0.2
31000 ± 4600
aProline was varied from 0-200 mM.
bKinetic parameters are from previous study49.
cCoQ was varied from 0 – 250 µM.
1
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The redox potential of the bound FAD is another indicator of the active site
environment. To determine whether the L1 linker has any direct impact on the
FAD binding site, the reduction potential of the FAD in ∆50-85 EcPutA was
determined. Figure 6 shows the plot of log(ox/red) of protein-bound FAD versus
log(ox/red) of resorufin. From this plot, a reduction potential of -111 mV for bound
FAD was determined along with a slope of 0.9629, which indicates 2-electron
transfer during reduction. The measured reduction potential of the FAD in ∆50-85
EcPutA is near that of WT EcPutA (-106 mV) suggesting the proteins share
similar FAD binding site environments.
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Figure 6. Redox potential of ∆50-85 EcPutA. The ∆50-85 EcPutA was mixed with
10 µM resorufin (indicator dye), 100 µM benzyl viologen (mediator dye), and 150
µM xanthine. The reduction of flavin is initiated by added 5 nM xanthine oxidase in
50 mM potassium phosphate, 150 mM NaCl, pH 7.5 buffer. Everything is degassed
and the reduction takes place in an anaerobic glove box. The spectrum has been
monitored every minute for 5 hours. The spectrum of every 10 minute is reported.
The intersect graph shows the log of intermediate dye and ∆50-85 EcPutA being
reduced which show a slope of 0.9629.
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Transcriptional regulation in vivo
Because Δ50-85 EcPutA was shown to have similar DNA binding, PRODH
activity, and functional membrane binding activity as shown above, we next sought
to determine whether Δ50-85 EcPutA was capable of regulating put gene
expression in response to proline. The ability of Δ50-85 EcPutA to function as
proline-responsive transcriptional regulator was tested in cells using a βgalactosidase assay. JT31 cells (lacZ-) transformed with pUC18 empty vector (EV),
pUC18-∆50-85 EcPutA, and pUC18- WT EcPutA were grown on M9 media in the
presence and absence of proline (15 mM). As expected, the negative control with
pUC18-EV showed repression of the putC:lacZ reporter gene with and without
proline (Figure 7). In contrast, both ∆50-85 EcPutA and WT EcPutA repressed lacZ
gene expression in the absence of proline. In the presence of proline, a 3-6-fold
increase in β-galactosidase activity was observed with ∆50-85 EcPutA and WT
EcPutA.
GSALDH activity and NAD+ utilization
The last functional domain to examine is the P5CDH domain (Figure 1) which
is spatially separated from the L1 region. Therefore, it seemed likely that ∆50-85
EcPutA would show similar GSALDH activity relative to WT EcPutA. However, the
kcat/KM for GSALDH activity by ∆50-85 EcPutA is only 350 M-1s-1 (Figure 8), which
is 5-fold lower than that of WT EcPutA (2000 M-1s-1).
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Figure 2. Cell-based assays of transcriptional regulation by ∆50-85 and WT
EcPutA. β galactosidase activity in the JT31 lacZ- E. coli strain containing the
putC:lacZ reporter construct and the pUC18 empty vector (EV), pUC18-∆50-85
EcPutA or puC18-WT EcPutA. Cells were grown on M9 medium in the absence
and presence of 15 mM proline. Miller units are reported as the average of four
replicates ± standard deviation.
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Figure 3. P5CDH activity of ∆50-85 EcPutA. 1 µM ∆50-85 EcPutA was mixed with
0.2 mM NAD+ and varied L-P5C (0-3000 µM) in potassium phosphate buffer (50
mM potassium phosphate, 150 mM NaCl, pH 7.5)
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To investigate the cause of the decreased GSALDH activity of ∆50-85 EcPutA
we examined NAD+ binding by intrinsic tryptophan fluorescence. Tryptophan
fluorescence of ∆50-85 EcPutA and WT EcPutA was monitored while varying
NAD+ concentration to determine the NAD+ binding constant (Figure 9). The KD of
WT and ∆50-85 EcPutA are 0.59 ± 0.16 and 0.83 ± 0.27 µM, respectively, and the
difference between the total fraction of PutA bound to NAD+ is not statistically
significant. We next determined the GSALDH kinetic parameters of ∆50-85 EcPutA
by holding P5C concentration fixed (3 mM) and varying NAD+. The kcat for ∆50-85
EcPutA was 2-fold lower than WT EcPutA but the KM for NAD+ was observed to be
similar to that of WT EcPutA (Table 2) further indicating no significant difference in
NAD+ utilization.
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Figure 4. Tryptophan fluorescent quenching with NAD+. 0.25 µM ∆50-85 or WT
EcPutA was mixed with 0-25 µM NAD+ excited at 290 nm and 335 nm emission
was collected.
Table 2. Kinetic constants for ∆50-85 EcPutA and WT EcPutA using varied NAD+
EcPutA
Activity Assay
KM (µM)
kcat(s-1)
kcat/KM(M-1s-1)
Enzyme
∆50-85
GSALDH
5.6 ± 1.8
0.82 ± 0.045
147000 ± 55000
a
WT
8.2 ± 3.5
1.564 ± 0.131
191000 ± 98000
∆50-85
Coupled
0.016 ± 0.0054
0.20 ± 0.015
12000 ± 4800
a
WT
0.024 ± 0.003
0.73 ± 0.1
31000 ± 4000
a
Values were determined previously39.
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PRODH-GSALDH coupled activity
The ability of ∆50-85 EcPutA to couple the overall oxidation of L-proline to Lglutamate was determined by mixing 0.1 µM with 20 mM proline, 0.2 mM CoQ1,
and 0.2 mM NAD+ and monitoring the NADH production at 340 nm (figure 10). The
KM of NAD+ for the ∆50-85 EcPutA coupled activity is similar to WT EcPutA but the
kcat is about 3-fold lower than that of WT EcPutA (Table 2). To test PRODHGSALDH coupled activity in vivo, we monitored the NADH production in living cells
expressing ∆50-85 EcPutA and WT EcPutA using the OLIS CLARiTY. Proline was
added to cells resuspended in phosphate buffer and the kinetics of FAD reduction
and NADH formation were monitored for 20 min. Proline induced reduction of FAD
and formation of NADH in cells with WT EcPutA (Figure 11A). In contrast, although
proline induced FAD reduction in cells with ∆50-85 EcPutA, no significant formation
of NADH was observed (Figure 11B). A plot of absorbance changes at 450 nm
(Figure 11C) and 340 nm (Figure 11D) from an average of 6 independent
replicates shows FAD reduction but no formation of NADH in cells with ∆50-85
EcPutA.
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Figure 5. The comparison
of ∆50-85 and WT EcPutA
channeling activity. 0.1 µM
enzyme was mixed with 0.2
mM CoQ1, 0.2 mM NAD+,
and 20 mM proline and
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340
was
tracked for 25 minutes.
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Figure 6. PRODH-GSALDH coupled activity in whole cells. BL21(DE3) putA- was
transformed with pET21a-∆50-85 EcPutA and pET21a-WT EcPutA expression
constructs and grown in LB. Cells were induced with 0.5 mM IPTG at OD600 0.6 for
3 h at 37 ˚C and resuspended in phosphate buffer (pH 7.5). PRODH-GSALDH
coupled activity in live cells with WT EcPutA (A) and ∆50-85 EcPutA (B) was
monitored by adding 15 mM proline and recording UV-visible spectra at 1 min
intervals for up to 20 min. Shown is the plot of FAD reduction and NADH formation
at 450 nm (C) and 340 nm (D) from 6 independent replicates.
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Melting temperature study
Since the ∆50-85 EcPutA shows lower GSALDH activity in vitro and in vivo, we
examined the stability of ∆50-85 EcPutA compared to WT EcPutA. We performed
thermal shift assays as well as a temperature dependent circular dichroism (CD)
study to determine the melting temperature (Tm) of ∆50-85 EcPutA. Because
cofactors can sometimes stabilize proteins, we also tested the impact of NAD+ on
the stability of ∆50-85 EcPutA. Figure 9A shows WT EcPutA has a higher Tm value
than ∆50-85 EcPutA by 2 oC. In the presence of NAD+, the stability of WT EcPutA
increased to a Tm value of 40.5 oC whereas NAD+ had no effect on the Tm of ∆5085 EcPutA. Thus, in the presence of NAD+, WT EcPutA shows a Tm that is 3 oC
higher than that of ∆50-85 EcPutA. Analysis of temperature stability by CD showed
similar Tm values for WT EcPutA and ∆50-85 EcPutA, however, in the presence of
NAD+, WT EcPutA exhibited a slightly higher Tm (1 oC) than that of ∆50-85 EcPutA
(Figure 12B and C).
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Figure 7. Melting temperature study of WT and ∆50-85 EcPutA. Tm values for WT
and ∆50-85 EcPutA from thermal shift assays (A) and CD spectroscopy (B) in the
absence and presence of 4 µM NAD+. (C), the melting temperature is obtained by
fitting the data to a logarithm curve. C is the Plot of the change in absorbance at
222 nm (A222) for WT and ∆50-85 EcPutA monitored by CD spectroscopy from 5 95 oC.
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Discussion
Linker regions in multidomain proteins are typically flexible to enable functional
coordination of different domains. In DNA-binding domains, the sequence of
linkers can also be important for DNA recognition26. The L1 linker region in EcPutA
was previously suggested to be highly flexible as it was identified by limited
proteolysis to undergo a conformational change in the presence of proline at
Ser5849. No structural information is currently available for the L1 region (50-85)
due likely to high conformational flexibility50. EcPutA constructs with (EcPutA 1-90)
and without (EcPutA 1-47) the L1 region were previously shown to exhibit DNAbinding activity. However, EcPutA1-90 exhibited a 7-fold lower binding affinity (KD
= 110 nM) to the putC DNA relative to EcPutA 1-47, (KD = 15 nM)21, which contains
only the RHH DNA binding domain. The weaker DNA binding affinity of EcPutA190 may be caused by the flexible L1 region interfering with DNA binding. In another
previous study Arentson and coworkers fused the DNA binding domain of EcPutA
to a type A bifunctional PutA from Rhodobacter capsulatus (RcPutA). The resulting
chimeric EcRHH-RcPutA lacked the L1 region but still could bind to the putC
intergenic DNA (KD = 58 nM) similarly to WT EcPutA21,23. Altogether, these results
show that the L1 linker does not contribute to DNA recognition.
Here, we conducted the first systematic study of the L1 linker in EcPutA. Our
results show that the L1 linker is not essential for EcPutA dimerization, DNA
binding and transcriptional repressor activity. Although the DNA-binding affinity of
∆50-85 EcPutA is 3-fold lower than WT EcPutA, ∆50-85 EcPutA is still able to
function as a transcriptional repressor in vivo. Deletion of the L1 linker in ∆50-85
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EcPutA had little impact on the FAD redox potential and PRODH activity and, did
not disrupt functional membrane association. Cell-based assays confirmed the
ability of ∆50-85 EcPutA to function as a proline-responsive transcriptional
regulator despite lacking the L1 linker. Thus, it seems that the L1 is not necessary
for EcPutA functional switching. The functional switching of trifunctional PutAs from
DNA binding to membrane association is analogous to pyruvate oxidase in which
flavin reduction triggers membrane binding, thereby enabling electron transfer to
the electron transport chain in the membrane51. Pyruvate oxidase has linkers that
interact with helices near the FAD binding domain that are released upon FAD
reduction thereby enabling pyruvate oxidase to associate with the membrane.
An unexpected finding from this study was the 5-fold decrease in GSALDH
activity in ∆50-85 EcPutA relative to WT EcPutA. Interestingly, a previous Nterminal truncation mutant of EcPutA (residues 86-1320) exhibited 2-fold lower
GSALDH activity relative to WT EcPutA.52 Another indication of lower GSALDH
activity in ∆50-85 EcPutA is the lack of NADH formation in whole cells upon adding
proline. Addition of proline to the cells quickly reduces FAD but unlike WT EcPutA,
no NADH production is observed. The apparent loss of GSALDH activity for ∆5085 EcPutA in vivo is not clear. NAD+ binding was shown to be similar between ∆5085 EcPutA and WT EcPutA. The melting curve studies using fluorescent dye
thermoshift assays and CD both show WT EcPutA has a slightly higher Tm than
∆50-85 EcPutA, which becomes more evident in the presence of NAD+. Thus,
NAD+ binding appears to stabilize WT EcPutA but not ∆50-85 EcPutA.
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Because the most significant impact of deleting the L1 linker is the loss of
GSALDH activity in ∆50-85 EcPutA, it seems most plausible that the L1 linker
contributes to the stabilization and function of the P5CDH domain. Studies that
provide structural insights into how the L1 linker could influence the GSALDH
domain will be the focus of future experiments. In addition, partially restoring the
L1 linker sequence may generate novel information on which residues in the 5085 region potentially impact the GSALDH domain.
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Appendix

Figure S1. The plasmid map of pET15b. The ∆50-85 EcPutA gene was inserted in
between NdeI and BamHI after the His-tag.
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S2. ∆50-85 EcPutA gene sequence
ATGGGAACCACCACCATGGGGGTTAAGCTGGACGACGCGACGCGTGAGCG
TATTAAGTCTGCCGCGACACGTATCGATCGCACACCACACTGGTTAATTAAG
CAGGCGATTTTTTCTTATCTCGAACAACTGGAAAACAGCGACACCTTGCCCC
AGTCGGTTTCCCGCGCCGCGATCACCGCGGCCTATCGCCGCCCGGAAACC
GAAGCGGTTTCTATGCTGCTGGAACAAGCCCGCCTGCCGCAGCCAGTTGCT
GAACAGGCGCACAAACTGGCGTATCAGCTGGCCGATAAACTGCGTAATCAA
AAAAATGCCAGTGGTCGCGCAGGTATGGTCCAGGGGTTATTGCAGGAGTTT
TCGCTGTCATCGCAGGAAGGCGTGGCGCTGATGTGTCTGGCGGAAGCGTT
GTTGCGTATTCCCGACAAAGCCACCCGCGACGCGTTAATTCGCGACAAAAT
CAGCAACGGTAACTGGCAGTCACACATTGGTCGTAGCCCGTCACTGTTTGT
TAATGCCGCCACCTGGGGGCTGCTGTTTACTGGCAAACTGGTTTCCACCCA
TAACGAAGCCAGCCTCTCCCGCTCGCTGAACCGCATTATCGGTAAAAGCGG
TGAACCGCTGATCCGCAAAGGTGTGGATATGGCGATGCGCCTGATGGGTG
AGCAGTTCGTCACTGGCGAAACCATCGCGGAAGCGTTAGCCAATGCCCGC
AAGCTGGAAGAGAAAGGTTTCCGTTACTCTTACGATATGCTGGGCGAAGCC
GCGCTGACCGCCGCAGATGCACAGGCGTATATGGTTTCCTATCAGCAGGC
GATTCACGCCATCGGTAAAGCGTCTAACGGTCGTGGCATCTATGAAGGGCC
GGGCATTTCAATCAAACTGTCGGCGCTGCATCCGCGTTATAGCCGCGCCCA
GTATGACCGGGTAATGGAAGAGCTTTACCCGCGTCTGAAATCACTCACCCT
GCTGGCGCGTCAGTACGATATTGGTATCAACATTGACGCCGAAGAGTCCGA
TCGCCTGGAGATCTCCCTCGATCTGCTGGAAAAACTCTGTTTCGAGCCGGA
ACTGGCAGGCTGGAACGGCATCGGTTTTGTTATTCAGGCTTATCAAAAACG
CTGCCCGTTGGTGATCGATTACCTGATTGATCTCGCCACCCGCAGCCGTCG
CCGTCTGATGATTCGCCTGGTGAAAGGCGCGTACTGGGATAGTGAAATTAA
GCGTGCGCAGATGGACGGCCTTGAAGGTTATCCGGTTTATACCCGCAAGGT
GTATACCGACGTTTCTTATCTCGCCTGTGCGAAAAAGCTGCTGGCGGTGCC
GAATCTAATCTACCCGCAGTTCGCGACGCACAACGCCCATACGCTGGCGGC
GATTTATCAACTGGCGGGGCAGAACTACTACCCGGGTCAGTACGAGTTCCA
GTGCCTGCATGGTATGGGCGAGCCACTGTATGAGCAGGTCACCGGGAAAG
TTGCCGACGGCAAACTTAACCGTCCGTGTCGTATTTATGCTCCGGTTGGCA
CACATGAAACGCTGTTGGCGTATCTGGTGCGTCGCCTGCTGGAAAACGGTG
CTAACACCTCGTTTGTTAACCGTATTGCCGACACCTCTTTGCCACTGGATGA
ACTGGTCGCCGATCCGGTCACTGCTGTAGAAAAACTGGCGCAACAGGAAG
GGCAAACTGGATTACCGCATCCGAAAATTCCCCTGCCGCGCGATCTTTACG
GTCACGGGCGCGACAACTCGGCAGGGCTGGATCTCGCTAACGAACACCGC
CTGGCCTCGCTCTCCTCTGCCCTGCTCAATAGTGCACTGCAAAAATGGCAG
GCCTTGCCAATGCTGGAACAACCGGTAGCGGCAGGTGAGATGTCGCCCGT
TATTAACCCTGCGGAACCGAAAGATATTGTGGGCTATGTGCGTGAAGCCAC
GCCGCGTGAAGTAGAACAGGCGCTGGAAAGTGCGGTTAATAACGCGCCAA
TCTGGTTTGCCACGCCTCCGGCTGAACGCGCAGCGATTTTGCACCGCGCTG
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CCGTGCTGATGGAAAGCCAGATGCAGCAACTGATTGGTATTCTGGTGCGTG
AGGCCGGAAAAACCTTCAGTAACGCCATTGCCGAAGTGCGCGAAGCGGTC
GATTTTCTCCACTACTACGCCGGACAGGTGCGGGATGATTTCGCTAACGAA
ACCCACCGTCCATTAGGGCCTGTGGTGTGTATCAGTCCGTGGAACTTCCCG
CTGGCTATTTTCACCGGGCAGATCGCCGCCGCACTGGCGGCAGGTAACAG
CGTGCTGGCAAAACCGGCAGAACAAACGCCGCTGATTGCCGCGCAAGGGA
TCGCCATTTTGCTGGAAGCGGGTGTACCGCCAGGCGTGGTGCAATTGCTGC
CAGGTCGGGGTGAAACCGTGGGCGCGCAACTGACGGGTGATGATCGCGTG
CGCGGGGTGATGTTTACCGGTTCAACCGAAGTCGCTACGTTACTGCAGCGC
AATATCGCCAGCCGCCTGGACGCTCAGGGTCGCCCTATTCCGCTCATCGCT
GAAACCGGCGGCATGAACGCGATGATTGTCGATTCTTCAGCACTGACCGAA
CAGGTCGTCGTGGATGTACTGGCCTCGGCGTTCGACAGTGCGGGTCAGCG
TTGTTCGGCGCTGCGCGTGCTGTGCCTGCAAGATGAGATTGCCGACCACAC
GTTGAAAATGCTGCGCGGCGCAATGGCCGAATGCCGGATGGGTAATCCGG
GTCGCCTGACCACCGATATCGGTCCAGTGATTGATAGCGAAGCGAAAGCCA
ATATTGAGCGCCATATTCAGACCATGCGTAGCAAAGGCCGTCCGGTGTTCC
AGGCGGTGCGGGAAAACAGCGAAGATGCCCGTGAATGGCAAAGCGGCACC
TTTGTCGCCCCGACGCTGATCGAACTGGATGACTTTGCCGAATTGCAAAAA
GAGGTCTTTGGTCCGGTGCTGCATGTGGTGCGTTACAACCGTAACCAGCTA
CCAGAGCTGATCGAGCAGATTAACGCTTCCGGTTATGGTCTGACGCTTGGC
GTCCATACGCGCATTGATGAAACCATCGCCCAGGTCACTGGCTCGGCCCAT
GTTGGTAACCTGTATGTTAACCGTAATATGGTGGGCGCAGTGGTTGGTGTG
CAGCCGTTCGGCGGCGAAGGGTTGTCCGGTACCGGGCCGAAAGCAGGCG
GTCCGCTCTATCTCTACCGTCTGCTGGCGAATCGCCCGGAAAGTGCGCTGG
CAGTGACGCTCGCGCGTCAGGATGCAAAGTATCCGGTCGATGCGCAGTTG
AAAGCCGCATTGACTCAGCCGCTAAATGCACTGCGGGAATGGGCAGCAAAT
CGTCCAGAATTGCAGGCGTTATGTACGCAATATGGCGAGCTGGCGCAGGC
AGGAACACAACGATTGCTGCCGGGGCCGACGGGTGAACGCAACACCTGGA
CGCTGCTGCCGCGTGAGCGCGTGTTGTGTATTGCCGATGATGAGCAGGAT
GCGCTGACTCAGCTCGCCGCCGTGCTGGCGGTGGGCAGCCAGGTACTGTG
GCCGGATGACGCGCTGCATCGTCAGTTAGTGAAGGCATTGCCATCGGCAG
TCAGCGAACGTATTCAACTGGCGAAAGCGGAAAATATAACCGCTCAACCGT
TTGATGCGGTGATCTTCCACGGTGATTCGGATCAGCTTCGCGCATTGTGTG
AAGCAGTTGCCGCGCGGGATGGCACAATTGTTTCGGTGCAGGGTTTTGCCC
GTGGCGAAAGCAATATCCTTCTGGAACGGCTGTATATCGAGCGTTCGCTGA
GTGTGAATACCGCTGCCGCTGGCGGTAACGCCAGCTTAATGACTATAGGTT
AA
S2. ∆50-85 EcPutA amino acid sequence with the first methionine highlighted.
The sequence before this methionine is from the pET15b plasmid.
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MGSSHHHHHHSSGLVPRGSHMGTTTMGVKLDDATRERIKSAATRIDRTPHWLI
KQAIFSYLEQLENSDTLPQSVSRAAITAAYRRPETEAVSMLLEQARLPQPVAEQ
AHKLAYQLADKLRNQKNASGRAGMVQGLLQEFSLSSQEGVALMCLAEALLRIP
DKATRDALIRDKISNGNWQSHIGRSPSLFVNAATWGLLFTGKLVSTHNEASLSR
SLNRIIGKSGEPLIRKGVDMAMRLMGEQFVTGETIAEALANARKLEEKGFRYSY
DMLGEAALTAADAQAYMVSYQQAIHAIGKASNGRGIYEGPGISIKLSALHPRYS
RAQYDRVMEELYPRLKSLTLLARQYDIGINIDAEESDRLEISLDLLEKLCFEPELA
GWNGIGFVIQAYQKRCPLVIDYLIDLATRSRRRLMIRLVKGAYWDSEIKRAQMD
GLEGYPVYTRKVYTDVSYLACAKKLLAVPNLIYPQFATHNAHTLAAIYQLAGQNY
YPGQYEFQCLHGMGEPLYEQVTGKVADGKLNRPCRIYAPVGTHETLLAYLVRR
LLENGANTSFVNRIADTSLPLDELVADPVTAVEKLAQQEGQTGLPHPKIPLPRDL
YGHGRDNSAGLDLANEHRLASLSSALLNSALQKWQALPMLEQPVAAGEMSPVI
NPAEPKDIVGYVREATPREVEQALESAVNNAPIWFATPPAERAAILHRAAVLME
SQMQQLIGILVREAGKTFSNAIAEVREAVDFLHYYAGQVRDDFANETHRPLGPV
VCISPWNFPLAIFTGQIAAALAAGNSVLAKPAEQTPLIAAQGIAILLEAGVPPGVV
QLLPGRGETVGAQLTGDDRVRGVMFTGSTEVATLLQRNIASRLDAQGRPIPLIA
ETGGMNAMIVDSSALTEQVVVDVLASAFDSAGQRCSALRVLCLQDEIADHTLK
MLRGAMAECRMGNPGRLTTDIGPVIDSEAKANIERHIQTMRSKGRPVFQAVRE
NSEDAREWQSGTFVAPTLIELDDFAELQKEVFGPVLHVVRYNRNQLPELIEQIN
ASGYGLTLGVHTRIDETIAQVTGSAHVGNLYVNRNMVGAVVGVQPFGGEGLSG
TGPKAGGPLYLYRLLANRPESALAVTLARQDAKYPVDAQLKAALTQPLNALRE
WAANRPELQALCTQYGELAQAGTQRLLPGPTGERNTWTLLPRERVLCIADDEQ
DALTQLAAVLAVGSQVLWPDDALHRQLVKALPSAVSERIQLAKAENITAQPFDA
VIFHGDSDQLRALCEAVAARDGTIVSVQGFARGESNILLERLYIERSLSVNTAAA
GGNASLMTIG
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the Metabolism of Thiazolidine Carboxylates. Biochemistry.

ABSTRACT
Thiazolidine

carboxylates

such

as

thiazolidine-4-carboxylate

(T4C)

and

thiazolidine-2-carboxylate (T2C) are naturally occurring sulfur analogs of proline.
These compounds have been observed to have both beneficial and toxic effects
in cells. Given that proline dehydrogenase has been proposed to be a key enzyme
in the oxidative metabolism of thioprolines, we characterized T4C and T2C as
substrates of proline catabolic enzymes using proline utilization A (PutA), which is
a bifunctional enzyme with proline dehydrogenase (PRODH) and L-glutamate-γsemialdehyde dehydrogenase (GSALDH) activities. PutA is shown here to
catalyze the FAD-dependent PRODH oxidation of both T4C and T2C with catalytic
efficiencies significantly higher than with proline. Stopped-flow experiments also
demonstrate that L-T4C and L-T2C reduce PutA-bound FAD at rates faster than
proline. Unlike proline, however, oxidation of T4C and T2C does not generate a
substrate for NAD+-dependent GSALDH. Instead, PutA/PRODH oxidation of T4C
leads to cysteine formation whereas oxidation of T2C generates an apparently
stable Δ4-thiazoline-2-carboxylate species. Our results provide new insights into
the metabolism of T2C and T4C.
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Abbreviations: ALDH, aldehyde dehydrogenase; CAM, carbamidomethylation;
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Sinorhizobium meliloti; Δ4-T2C, Δ4-thiazoline-2-carboxylate; Δ2-T4C, Δ2-thiazoline4-carboxylate; T4C, thiazolidine-4-carboxylate; T2C, thiazolidine-2-carboxylate
(T2C); THFA, tetrahydro-2-furoic acid.

INTRODUCTION
L-proline is unique among the natural amino acids due to the heterocyclic ring
and secondary amine. Besides being essential for protein biosynthesis, L-proline
has been shown to have critical roles in cellular bioenergetics, redox homeostasis,
stress response, osmoprotection, and bacterial pathogenesis.1-5 Biological
compounds rich in proline have also been shown to have promising antimicrobial
therapeutic properties.6-9 One group of naturally occurring sulfur-containing proline
analogs that are of important interest includes thiazolidine-4-carboxylate (T4C)
and thiazolidine-2-carboxylate (T2C) (Scheme 1). T4C is a condensation product
of L-cysteine and formaldehyde10, 11 whereas T2C is generated from glyoxylate
and cysteamine.12 T4C has been reported to serve as a nutrient and cysteine
source13,

14

, act as an antioxidant4,

15

and scavenge free radicals such as
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nitroxide.16,

17

Suggested therapeutic benefits of T4C include treatment of liver

disease,16 inhibition of cancer cell growth and reversal of advanced cancer,18-21
and prevention of aging related diseases.22, 23 T4C is also an important building
block of ß-lactam antibiotics.24

Scheme 1. Chemical structures of T2C and T4C.
Thioprolines have the potential to be toxic due to misincorporation into proteins
or inhibition of protein synthesis.25-28 In Escherichia coli, it was recently discovered
that the Xaa-Pro aminopeptidase, PepP, could rescue thioproline toxicity by
removing thioproline misincorporated peptides.11 Intracellular toxic levels of T4C
have been proposed to be diminished through oxidative metabolism via the
enzymes proline dehydrogenase (PRODH) and Δ1-pyrroline-5-carboxylate
reductase (PYCR).11,

29-31

PRODH was implicated first in L-T4C metabolism in

assays using mitochondrial29 and E. coli membrane fractions.30 Later, E. coli PYCR
was also reported to catalyze the oxidation of T4C via a NAD+-dependent
reaction.31 D-T2C was shown previously to be a substrate for D-amino acid
oxidase which converts D-T2C to Δ2-thiazoline-2-carboxylate.12
Although considered to have a prominent role in oxidative metabolism of
thioprolines, to our knowledge the kinetic properties of a PRODH enzyme with T4C
or T2C have not been determined. PRODH is a FAD-dependent enzyme that
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Scheme 2. Reactions catalyzed by proline catabolic enzymes.
catalyzes the 2-electron oxidation of L-proline to Δ1-pyrroline-5-carboxylate (P5C,
Scheme 2). This reaction is coupled to reduction of ubiquinone in the cytoplasmic
membrane and in eukaryotes, the mitochondrial respiratory chain.1,

32-34

P5C

subsequently undergoes hydrolysis to form L-glutamate-γ-semialdehyde (GSAL),
which is then oxidized by the NAD+-dependent aldehyde dehydrogenase
superfamily member GSALDH (a.k.a. ALDH4A1, P5CDH) to form L-glutamate
(Scheme 2). The 4-electron oxidation of L-proline to L-glutamate by the
consecutive reactions of PRODH and GSALDH is conserved among prokaryotes
and eukaryotes.35,

36

In Gram-negative bacteria, PRODH and GSALDH are

encoded in the same polypeptide chain, known as proline utilization A (PutA).35
To provide insights into the metabolic routes of T4C and T2C oxidation, we
investigated the potential of PutA from Sinorhizobium meliloti (SmPutA) to use
these compounds as substrates. SmPutA is well structurally characterized37 and
recently, L-T2C was reported to covalently modify the flavin cofactor of SmPutA38;
however, the modification occurred over a long incubation period (measured in
days) and the kinetics of T2C oxidation were not characterized. Using SmPutA, we
show here that both T4C and T2C are facile substrates with PRODH but that the
oxidized products do not generate aldehyde substrates for GSALDH. We show
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that T4C is oxidized to Δ2-thiazoline-4-carboxylic acid (Δ2-T4C), which
subsequently hydrolyzes to form cysteine, whereas T2C is oxidized to Δ4thiazoline-2-carboxylate (Δ4-T2C) and does not generate additional products.

EXPERIMENTAL PROCEDURES
Materials. All chemicals and buffers were purchased from Fisher Scientific and
Sigma-Aldrich, unless otherwise noted. DL-P5C was synthesized according to the
method of Williams and Frank and stored in 1 M HCl at 4 oC.39 P5C concentrations
were determined by adding o-aminobenzaldehyde (o-AB) and measuring the
absorbance at 443 nm (ε443 nm = 2590 M-1 cm-1).39
Purification of SmPutA. SmPutA was expressed in Escherichia coli
BL21(DE3) pLysS using the pNIC28 expression vector as previously described.37,
38

A 5-mL overnight culture grown in LB was used to inoculate a 4 L-LB culture.

Cells were grown at 37 ˚C until an OD600 of 0.6, at which point protein expression
was induced with 0.25 mM IPTG for 10 h at 18 ˚C. Cells were harvested and then
resuspended (1:10 ratio of wet cell mass to buffer volume) in 50 mM Tris buffer
(pH 7.8) containing 300 mM NaCl, 5 mM imidazole, 5% glycerol, five protease
inhibitors (3 mM ε-amino-N-caproic acid, 0.3 mM phenylmethylsulfonyl fluoride, 1.2
µM leupeptin, 48 µM tosyl phenylalanyl chloromethyl ketone, and 78 µM tosyllysine
chloromethyl 47 ketone hydrochloride), 20 µM FAD and 0.2% Triton-100.
Resuspended cells were lysed on ice via sonication using a model 550 Sonic
Dismembrator (Fisher Scientific) with a power setting of 5 for 5 min total using a
pulse sequence of 5 s on and 15 s off. Cell lysed material was centrifuged at 20,000
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g using a JA 20 rotor for 30 min and the supernatant was collected. The
supernatant was passed through a 0.22 µm filter before loading onto a HisPur NiNTA Superflow Agarose (Thermo Fisher Scientific) packed in a borosilicate glass
column. The flow-through was loaded back onto the column again before washing
and eluting with buffers resembling the binding buffer except with increasing
imidazole concentrations (20 mM, 40 mM, and 300 mM). The eluted SmPutA was
collected in 2 mL fractions, and SDS-PAGE under reducing conditions was used
to determine the purity of the fractions. The selected fractions were pooled and
dialyzed at 4˚C against dialysis buffer (50 mM Tris, 150 mM NaCl, 0.5 mM EDTA,
0.5 mM Tris(hydroxypropyl)phosphine, 10% glycerol, pH 7.8). The dialyzed protein
was then concentrated via Amicon stirred cell using a 30 kDa molecular weight
cut-off ultrafiltration disc from MilliporeSigma. The concentrated protein was flashfrozen in 500 µL aliquots and stored at -80 oC. The N-terminal hexahistidine tag
was retained in purified SmPutA. The concentration of PutA was determined using
the BCA method (Pierce) and spectrophotometrically using a molar extinction
coefficient of 12700 M-1 cm-1 at 451 nm.40
Steady-state PRODH Kinetics. The PRODH activity of SmPutA with different
substrates was studied by monitoring the reduction of the electron acceptor
Coenzyme Q1 (CoQ1) by absorbance at 278 nm (ε278 = 14.3 mM-1cm-1)41 using 1mL cuvettes and a Varian Cary 50 UV-visible spectrophotometer as previously
described.42 The assay buffer contained 50 mM potassium phosphate and 25 mM
NaCl at pH 7.5. All substrate stock solutions were made in sodium phosphate
buffer (pH 7.5). The substrates and CoQ1 (final concentration of 0.2 mM) were
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incubated in assay buffer for 5 min at room temperature before SmPutA (final
enzyme concentration of 0.25 µM) was added to initiate the reaction. The substrate
concentration was varied as follows: L-proline, 0 – 200 mM; L-T4C, 0 – 3 mM; and
L-T2C, 0 – 2.5 mM. We note that T2C is commercially available only as a racemic
mixture. All data are reported using the concentration of L-T2C, which was
considered to be half of the DL-T2C concentration. The initial velocity (v0) was
determined from the linear portion of the progress curve (0-5 min). Assays were
performed in triplicate. Kinetic parameters were estimated by fitting initial rates to
the Michaelis-Menten equation using SigmaPlot 12.0.43 Plotted is vo/[E] versus
substrate concentration where V is the maximal reaction velocity of CoQ1 reduction
and [E] is the concentration of SmPutA used in the assays (0.25 µM).
Steady-state PRODH-GSALDH Coupled Activity Assay. The PRODHGSALDH coupled activity of PutA with L-proline, L-T2C, and L-T4C was studied
as previously described.44 The reactions contained 0.25 µM SmPutA, 0.2 mM
CoQ1 as an electron acceptor, 0.2 mM NAD+, and L-proline (20 mM), L-T4C (5 mM)
or L-T2C (5 mM) in the assay buffer (50 mM potassium phosphate, 25 mM NaCl,
pH 7.5). The coupled activity was measured by monitoring NADH production at
340 nm (ε340 =6.22 mM-1 cm-1).
Single-turnover PRODH Kinetics. All stopped-flow kinetic measurements
were conducted with a Hi-Tech Scientific SF-61DX2 stopped-flow instrument
equipped with a photodiode array detector at 23 oC as previously described.38, 44
Enzyme, buffer, and substrate solutions were degassed using 12 cycles of vacuum
and nitrogen. All substrate solutions were made in 50 mM phosphate buffer (25
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mM NaCl, pH 7.5). In addition, 100 µM protocatechuic acid (PCA) and 0.05 U/mL
protocatechuate 3,4-Dioxygenase (PCD) were included in the substrate solutions
to scrub residual oxygen.45 SmPutA enzyme was rapidly mixed by stopped-flow
with an equal volume of the following substrates at varied concentrations (all
reported concentrations are after mixing): L-T4C (0 – 100 mM), L-T2C (0 – 100
mM), and L-proline (0 – 1000 mM). The reactions were monitored by
multiwavelength absorption from 300-700 nm. The decrease in absorbance at 450
nm was fit to equation 1 using SigmaPlot 12.0 to obtain the observed rate
constants (kobs1 and kobs2) where Ao is the initial absorbance at 450 nm and A1 and
A2 are the corresponding amplitudes. KD values were determined by plotting kobs1
versus substrate concentration. The maximum observed rate constant (kmax) and
the apparent KD were determined by fitting kobs1 to equation 2 as a function of
substrate concentration ([S]).
A(450) = A0 + A1*e(-kobs1*t) + A2*e(-kobs21*t)
kobs1 = (kmax*[S])/(KD + [S])

(eq 1)
(eq 2)

To test PRODH-GSALDH coupled activity under single turnover conditions,
SmPutA enzyme was rapidly mixed by stopped-flow with an equal volume of
substrate solution containing 0.2 mM NAD+ and 20 mM L-T4C, L-T2C, and Lproline. The reactions were monitored by multi-wavelength absorption from 300700 nm.
Prediction of pKa Values. The pKa values of the nitrogen in proline, T2C, T4C,
P5C, Δ2-T4C and Δ4-T2C were calculated using the structure-based chemical
property prediction tool Chemicalize (https://chemicalize.com).46
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Characterization

of

Products

by

Electrospray

Ionization

Mass

Spectrometry. Electrospray ionization mass spectrometry (ESI-MS) was used to
characterize the products generated during the reaction of SmPutA with L-T2C and
L-T4C. The reaction mixtures contained after mixing (final concentration) 0.5 mM
substrate (L-T4C or L-T2C) (pH 7.5) and 0.5 mM CoQ1 in 50 mM potassium
phosphate buffer (50 mM NaCl, pH 7.5). The reactions were initiated by adding
PutA (2 µM final concentration after mixing) except for the control sample (no
enzyme). The reaction mixtures were then incubated for 60 min at 23 °C followed
by ESI-MS analysis. To test whether the reaction products also lead to cysteine
formation, 1 mM iodoacetamide (final concentration after mixing) was added to
each sample and the samples were incubated for an additional 10 min at 37 °C to
allow for alkylation of thiol species, which yields stable carbamidomethylation
(CAM) product compounds.
Samples were then transferred into polyethylene V-vials and sealed with Altops. The samples were kept at 5 °C in the autosampler of the LC-1200 HPLC
(Agilent, Santa Clara, CA) prior to column chromatography. Samples were applied
onto an Amide X-Bridge (2.1 mm x 150 mm, Waters, Milford, MA) column running
at 350 µl/min at 25 °C with a gradient starting at 95% A (5% B) for 2 min, gradient
to 55% A over 5 min, gradient to 5% A over 20 min, then 2 min hold at 5% A,
followed by re-equilibration with 95% acetonitrile (A) for 10 min. The mobile phases
consisted of acetonitrile (LC-Grade) (A) and 20 mM ammonium acetate in water
(LC-Grade) supplemented with 20 mM ammonium hydroxide (B, pH 9.5). The
4000-QTrap mass spectrometer (Sciex, Framingham, MA) were set to operate in
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single quadrupole, multiple reaction monitoring (MRM), and MS/MS modes. The
general electrospray conditions were: electrospray ionization (ESI) potential =
5000 V, temperature = 500 °C, ion source gas 1 = 60 L/min, ion source gas 2 = 80
L/min, curtain gas = 20 L/min, declustering potential = 60 V, collision entrance
potential = 10 V, and collision exit potential = 15 V. The collision energy values for
the individual compounds were optimized by injections of authentic standards and
were within the range of 15-30 V. The data were collected and analyzed with
Analyst version 1.6.1 and plotted using SigmaPlot 14.0.
Nuclear Magnetic Resonance (NMR) Analysis of T2C and T4C Reaction
Products. NMR spectra were acquired on a Bruker Avance NEO 600 MHz NMR
spectrometer equipped with a 5 mm TCI-H/F cryoprobe. All spectra were acquired
under dark lab conditions with overhead lights switched off. Proton spectra were
gathered before and after addition of the enzyme to the reaction mixtures.
Deuterium oxide was added to the reaction mixture for spectrometer lock with LT2C, or for L-T4C, the reaction mixture was prepared primarily using deuterium
oxide instead of water. For NMR analyses, CoQ1 was dissolved in DMSO-d6 and
quantified using extinction coefficient 14.3 mM-1cm-1 at 275 nm. In the reaction
(250 µL total volume) with L-T2C, 2 µM SmPutA was mixed with 0.5 mM CoQ1,
and 0.5 mM L-T2C in 50 mM phosphate buffer (50 mM NaCl, pH 7.5). 20 µL of
deuterium oxide was added to the reaction mixture as noted above. Reactions
were initiated by adding SmPutA and quickly transferred to an NMR tube and
incubated for 60 min at 25 oC during data acquisition. For the reaction with L-T4C,
SmPutA was first flash-frozen and lyophilized, then resuspended in deuterated
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water. The 50 mM potassium phosphate buffer (50 mM NaCl, pH 7.5) and L-T4C
were also prepared in deuterated water. The reaction mixture (250 µL total volume)
included 0.5 mM CoQ1, 0.5 mM L-T4C and 2 µM SmPutA. Reactions with L-T4C
were initiated by adding SmPutA and incubated in an NMR tube for 60 min at 25
o

C during data acquisition.

RESULTS
Steady-state PRODH Kinetics. The ability of SmPutA to use L-T2C and LT4C as substrates was first tested using the PRODH activity assay. SmPutA
displayed robust PRODH activity with both compounds (Figure 1). The steadystate kinetic parameters for L-T2C, L-T4C, and L-proline are reported in Table 1.
The kcat values range 0.7-1.4 s-1 whereas the KM values for the thiazolidine
carboxylates are about 30-fold lower relative to L-proline. As a result, the catalytic
efficiencies with L-T2C and L-T4C are about 20-30 times higher than with L-proline.
These results show that the SmPutA PRODH domain effectively catalyzes the
oxidation of L-T2C and L-T4C.
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Figure 1. PRODH activity with thiazolidine carboxylates. SmPutA (0.25 µM) was
mixed with (A) L-proline (0-200 mM), (B) L-T2C (0-2.5 mM), and (C) L-T4C (0-3
mM) as the varied substrate and 0.2 mM CoQ1 as the fixed substrate. The data
are fit to the Michaelis-Menten equation.
Table 1. Steady-state Kinetic Parameters of SmPutA PRODH Activity
with Thioproline Substrates
Varied Substrate
KM (mM)
kcat (s-1)
kcat/KM (M-1s1
)
L-T2C
0.22 ± 0.05
0.7± 0.1
3000 ± 1600
L-T4C
0.24 ± 0.08
1.2 ± 0.1
4900 ± 2100
L-Proline
7.7 ± 1.8
1.4± 0.1
149 ± 41
Assays used 0.25 µM SmPutA and 0.2 mM CoQ1 and, 0-2.5 mM L-T2C, 0-3
mM L-T4C, or 0-200 mM L-proline.
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A hallmark of PutAs is the ability to catalyze the coupled PRODH/GSALDH
reaction involving P5C as the intermediate. To test whether the oxidized products
of L-T2C and L-T4C from the PRODH reaction can be used as substrates by the
GSALDH domain, coupled activity assays were conducted. Figure 2 shows that in
contrast to proline, utilization of L-T2C and L-T4C did not result in NADH formation,
indicating that oxidation of these thiazolidine carboxylates by the PRODH domain

Absorbance 340 (a.u.)

does not generate a usable substrate for GSALDH.

0.15

L-Proline

0.10

L-T2C
0.05

L-T4C

0.00
10
-0.05

20

30

40

Time (min)

Figure 2. SmPutA coupled activity. SmPutA (0.25 µM) was mixed 0.2 mM NAD+,
0.2 mM CoQ1, and proline (20 mM), L-T2C (5 mM) or L-T4C (5 mM). NADH
formation with L-proline is indicated by an increase in absorbance at 340 nm.

Single-turnover Studies. The rates of L-T2C and L-T4C reduction of SmPutA
bound-FAD were determined next by rapidly mixing SmPutA with the different
substrates. All substrates resulted in complete reduction of the bound FAD as
shown in Figure 3. Reduction of the FAD occurred in two phases, with kobs1
corresponding to the major amplitude change in the spectrum. The maximum
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observed rate constant for FAD reduction was determined by plotting kobs1 versus
substrate concentration. As shown in Figure 4 and reported in Table 2, L-T4C
resulted in the highest maximal observed rate constant (kmax), about 4-fold higher
than that determined with proline. Thus, L-T2C and L-T4C are facile reducing
substrates of the FAD in SmPutA.

Figure 3. UV-visible spectra of PutA reduction by thioproline substrates. Reduction
of PutA (32 µM, after mixing) with 20 mM (after mixing) (A) L-proline, (B) L-T2C
and (C) L-T4C. Shown in each inset is the fit of the absorbance change at 450 nm
to a double exponential decay (equation 2). The kobs1 values estimated from the
best-fits are 7.2 s-1 (L-proline), 32 s-1 (L-T2C), and 53 s-1 (L-T4C).
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Figure 4. Single-turnover kinetics of SmPutA PRODH domain. SmPutA (32 µM,
after mixing) was mixed with 0-200 mM L-Proline (A), 0-50 mM L-T2C (B), and 0100 mM L-T4C (C). Shown is the fit of the data to eq 2 from which the
parameters kmax and KD were determined.

Table 2. Single-turnover Kinetic Constants of SmPutA/PRODH
Activity
Varied Substrate
kmax (s-1)
KD (mM)
L-Proline
43.4 ± 5.7
48 ± 17
L-T2C
91.4 ± 10.8
9.1 ± 3.4
L-T4C
181 ± 19
26 ± 8
The coupled reaction of SmPutA was then monitored by stopped-flow to test
whether oxidation of L-T2C and L-T4C lead to formation of NADH under single-
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turnover conditions. Figure 5 shows reduction of FAD and NADH formation
measured at 450 and 340 nm, respectively. As expected, mixing SmPutA with
proline causes reduction of FAD and generates NADH, consistent with coupled
PRODH-GSALDH activity. In contrast, mixing SmPutA with L-T2C and L-T4C
result only in reduction of FAD with no NADH formation observed. These results
confirm that the oxidized products of L-T2C and L-T4C are not substrates for the

[FAD] or [NADH] (µM)

GSALDH domain in SmPutA.
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Figure 5. Stopped-flow reaction of coupled PRODH-GSALDH activity in SmPutA.
SmPutA (25 μM, after mixing) was rapidly mixed with 0.2 mM NAD+ and 20 mM Lproline, L-T2C, or L-T4C. Shown are the changes in concentration for FADox
(squares) and NADH (open circles) for the reaction of PutA with each substrate.
No NADH formation is observed with L-T2C and L-T4C.
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MS and NMR Analysis of T2C and L-T4C Products. The oxidized products of LT2C and L-T4C generated by SmPutA were then characterized by mass
spectrometry and NMR. Mass spectrometry data of the reaction of SmPutA with
L-T4C and L-T2C showed evidence for 2,3-thiazoline-4-carboxylate (or Δ2-T4C,
m/z 132) and 3,4-thiazoline-2-carboxylate (or Δ4-T2C, m/z 132), respectively
(Figure 6). L-T4C and L-T2C, which have the same parent 134 m/z, share the
same oxidized m/z of 132. The new 132 m/z species is consistent with a hydride

Figure 6. Mass spectrometry of L-T2C and L-T4C reaction products. (A) L-T4C
before and (B) after the reaction with SmPutA. (C) DL-T2C before and (D) after
the reaction with SmPutA. Oxidized products of T4C and T2C are indicated by
the appearance of the 132 m/z peak. Reaction mixtures contained 2 µM
SmPutA, 0.5 mM CoQ1, 0.5 mM L-T2C or L-T4C, in 50 mM potassium phosphate
buffer (50 mM NaCl, pH 7.5).
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transfer to the bound FAD and formation of a double bond during the reaction with
PutA. Because mass spectrometry did not distinguish at which carbon L-T4C and
L-T2C are oxidized, NMR was used to further confirm the reaction products. Figure
7A shows the NMR spectrum of the products from the reaction of PutA and L-T2C.
The results provide evidence that the C4 atom is oxidized in the reaction (i.e., Δ4T2C is the product). Likewise, oxidation of the C2 atom in L-T4C was indicated in
the NMR spectrum of the reaction with L-T4C (Figure 7B). Because water
suppression interfered with assignment of the proton at the C4’ position of Δ2-T4C
at 4.80 ppm, a sample was prepared using only deuterium oxide as the solvent
and analyzed by COSY NMR. COSY NMR spectra (Figure S1) shows clear
assignment of the C4’ proton of Δ2-T4C further confirming Δ2-T4C as the product.
These results suggest that L-T2C and L-T4C are oxidized by SmPutA in a hydride
transfer mechanism similar to proline.
To test whether PutA mediated oxidation of L-T2C and L-T4C leads to cysteine
formation, reaction products were incubated with iodoacetamide and analyzed by
ESI-MS. Figure S3 shows a Cys-CAM species (m/z 179) in the reaction with LT4C, indicating cysteine is generated in the reaction. No Cys-CAM was detected
in reactions with L-T2C; thus, formation of a free sulfur species is unique to
oxidation of L-T4C.
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Figure 7. NMR spectra of T2C and T4C reaction products. (A) Proton NMR
spectrum of Δ4-T2C after reacting L-T2C and SmPutA for approximately one hour.
(B) Proton NMR spectrum of Δ2-T4C after reacting L-T4C and SmPutA for
approximately one hour. Proton of the C4’ position of Δ2-T4C at 4.80 ppm is not
visible due to water suppression. NMR spectra of T2C and T4C before addition of
SmPutA are provided in Figure S2.
DISCUSSION
PutA was shown here to readily use L-T2C and L-T4C as substrates for the
PRODH reaction. Rapid reaction kinetics show the maximum rate of FAD reduction
is faster with the thiazolidine carboxylate substrates than with L-proline and the
lower KD values estimated for L-T2C and L-T4C compared to L-proline indicate
these alternative substrates bind with strong affinity to the PRODH active site. The
oxidative step was previously determined to be rate-limiting for kcat during catalytic
turnover for the proline:ubiquinone oxidoreductase activity of PutA.47 Thus,
although the rate of flavin reduction is higher with T2C and T4C, the overall kcat
does not increase. The catalytic efficiency of PutA with the thiazolidine
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carboxylates is significantly higher than with L-proline due to the lower KM values
for T2C and T4C. L-T2C was shown recently to be a mechanism-based inactivator
of SmPutA, however, the inactivation is very slow with an apparent pseudo-first
order rate constant for of 0.44 days–1.38 Thus, inactivation of SmPutA by T2C is
not expected to occur under the conditions used here for the steady-state and rapid
reaction experiments.
Covalent modification of FAD by L-T2C was observed in crystals of SmPutA
that were derived from co-crystallization of SmPutA and DL-T2C.38 A crystal
structure of the inactivated enzyme showed L-T2C forms a covalent bond between
the C5 of T2C and N5 of reduced FAD.38 The T2C covalent adduct was observed
to occupy the same site as L-tetrahydro-2-furoic acid (L-THFA), a competitive
inhibitor that mimics proline binding and ion pairs with active site residues Arg488,
Arg489, and Lys265 (Figure 8A)38. The structural similarity of L-T2C and L-T4C to
L-proline suggests that these alternative substrates bind to the PRODH active site
like L-proline. Manual docking calculations based on the L-THFA complex
structure (PDB 5KF6) suggest that the C4 of L-T2C and the C2 of L-T4C can
approach the FAD N5 within 3.2 Å without introducing any steric clashes in the
structure. For reference, the analogous distance for the L-THFA complex is 3.3 Å.
These results are consistent with L-T2C and L-T4C binding PRODH like L-THFA
and proline (see Figure 8A), allowing for hydride transfer from the C4 and C2 atoms
of L-T2C and L-T4C, respectively, to the FAD N5 in SmPutA. A reaction
mechanism for the reduction of SmPutA-bound FAD by L-T4C is proposed in
Figure 8B. The electronegative sulfur atom in the pyrrolidine ring likely increases
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the acidity of the C4 and C2 atoms in L-T2C and L-T4C, respectively, enabling
these compounds to be facile reducing substrates of the bound FAD.48 Using the
software program Chemicalize (http://www.chemaxon.com), pKa values for the
secondary amine in T4C and T2C were both calculated to be 7.7. The calculated
value for T4C is higher than the experimentally determined pKa value of 6.24
reported previously for T4C.49 Thus, L-T2C and L-T4C may already have the
secondary amine deprotonated in the enzyme bound form due to the much lower
pKa of the nitrogen atom relative to L-Pro (calculated pKa = 11.3).49,
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These

chemical properties may explain why L-T2C and L-T4C are faster reducing
substrates than proline.
Figure 9 shows the steps for the non-enzymatic hydrolysis of P5C that leads to
formation of GSAL, the substrate for the GSALDH domain. An interesting
observation here is that no formation of NADH is observed with T4C and T2C,
indicating that unlike P5C, Δ2-T4C and Δ4-T2C are not able to continue along the
PRODH/GSALDH coupled reaction pathway. It was also noted in the inactivation
study of SmPutA with T2C that NADH was not generated under single turnover
conditions.38 In considering possible explanations for the lack of usable substrates
for GSALDH, we sought to determine whether oxidation of these compounds lead
to alternative products. We detected cysteine as a reaction product with L-T4C,
which as depicted in Figure 9, is formed by hydrolysis of Δ2-T4C to N-formylcysteine and subsequently hydrolyzed to release cysteine and formate.11,
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In

contrast to T4C, SmPutA oxidation of T2C did not generate other detectable
species besides Δ4-T2C (Figure 9).

85

A

B
O

O
S

O
HN
H 3C

H 3C

H
H

S

O
HN

O

N

N

N

O

R

O

H 3C

H H
N

H 3C

N

N
H

O

R

Figure 8. Structure of substrate binding site and proposed hydride transfer mechanism. (A)
Structure L-THFA bound to the PRODH active site in SmPutA (PDB 5KF6).37 Figure
adapted from Campbell, A. C.; Becker, D. F.; Gates, K. S.; Tanner, J. J. Covalent
Modification of the Flavin in Proline Dehydrogenase by Thiazolidine-2-Carboxylate. ACS
Chem. Biol. 2020, 15, 936-944.38 (B) Proposed oxidation mechanism of L-T4C.
Mechanism was drawn using ChemDraw 20.
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Figure 9. Predicted pKa values for P5C and thiazolidine carboxylates and
hydrolysis products. The pKa values for protonation of the nitrogen in P5C, Δ2-T4C
and Δ4-T2C. Hydrolysis of the protonated species are shown generating GSAL and
N-formyl-Cys from P5C and Δ2-T4C, respectively. Hydrolysis of N-formyl-Cys to
generate free cysteine and formaldehyde is not shown. Hydrolysis products from
Δ4-T2C were not detected. Figure drawn with ChemDraw 20.

Curious as to why Δ4-T2C appears less susceptible to hydrolysis under the
assay conditions (pH 7.5), we considered that the sulfur atom may have a
significant impact on the pKa of the nitrogen. Hydrolysis and ring-opening of P5C
to form GSAL is favored when the nitrogen is protonated (Figure 9). The pKa values
of the nitrogen in P5C, Δ2-T4C and Δ4-T2C were thus estimated using the software
program Chemicalize from ChemAxon (http://www.chemaxon.com). The predicted
pKa of the nitrogen atom in P5C is 6.1, which is only slightly lower than the
experimentally determined value of 6.67.52 Surprisingly, the pKa values for the
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nitrogen atom in Δ2-T4C (pKa 1.8) and Δ4-T2C (pKa 1.5) are predicted to be over 4
pH units more acidic than that of P5C (Figure 9). This highly suggests that the
nitrogen is predominantly deprotonated in the enzyme bound forms of Δ2-T4C and
Δ4-T2C. Thus, hydrolysis may be impeded by the much lower pKa of the nitrogen
atom in Δ2-T4C and Δ4-T2C (Figure 9). In the case of Δ2-T4C, however, the ringopening step that leads to N-formyl-cysteine formation may shift the equilibrium in
favor of hydrolysis.
In conclusion, steady-state and single-turnover kinetic studies provide strong
evidence that L-T2C and L-T4C are facile substrates of the PRODH active site in
PutA. The ESI-MS and NMR results support a hydride transfer mechanism leading
to the oxidized products Δ2-T4C and Δ4-T2C. The carbon-sulfur bond in thioproline
has been shown to increase the perimeter of the pyrrolidine ring and impact the
energy levels of different conformers relative to proline.24 This could enhance
binding of thioproline to the PRODH active site which may be reflected in the lower
KM and KD values determined for L-T2C and L-T4C. Potentially this would explain
why L-T4C has been reported to inhibit proline metabolism at concentrations much
less than proline.53 Another chemical effect of sulfur that likely enhances FAD
reduction by thioproline is the increased acidity of the nitrogen and adjacent carbon
atom. Altogether, PutA exhibits efficient catalytic activity with L-T2C and L-T4C,
thus further implicating PRODH as a key enzyme for lowering intracellular levels
of thioprolines and, in the case of L-T4C, generating cysteine.
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APPENDEX A: SUPPORTING INFORMATION

Figure S1. COSY NMR Spectra of SmPutA reaction with L-T4C. Reaction mixture (250
µL total volume) was prepared using deuterium oxide as the solvent, including 0.5 mM
CoQ1, 0.5 mM L-T4C and 2 µM SmPutA was incubated for 60 min at 25 oC.
Assignment of the C4’ proton at 4.8 ppm is observed confirming Δ2-T4C as the reaction
product.
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A

B

Figure S2. NMR spectra of unreacted T2C and T4C mixtures. (A) Proton NMR spectrum
of DL-T2C reaction mixture before addition of SmPutA. (B) Proton NMR spectrum of LT4C reaction mixture before addition of SmPutA.
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Figure S3. Electrospray ionization mass spectrometry (ESI-MS) detection of cysteine
from SmPutA and L-T4C. SmPutA (2 µM) was mixed with 0.5 mM L-T4C or L-T2C and
0.5 mM CoQ1 in 50 mM potassium phosphate buffer (50 mM NaCl, pH 7.5).Reaction
mixtures were incubated for 60 min at 23 °C after which 1 mM iodoacetamide (final
concentration after mixing) was added to each sample and the samples were incubated for
an additional 10 min at 37 °C to allow for alkylation of thiol species. (A) MS/MS spectra
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of a control reaction of cysteine + iodoacetamide. (B) MS/MS spectra of carbamoylated
derivatives of cysteine from the reaction of SmPutA and L-T4C. (C) MS/MS spectra
from the reaction of SmPutA and L-T2C. Mass spectra data were analyzed with Analyst
version 1.6.1 and plotted using SigmaPlot 14.0. The major fragment peaks for Cys-CAM
are observed at m/z = 162.3, 144.2, 133.2 116.3, 90.2 and 88.2.
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Chapter 4. Insights into substrate channeling of proline utilization A (PutA)
in Sinorhizobium meliloti
Abstract
Proline utilization A (PutA) is a bifunctional enzyme consisting of proline
dehydrogenase (PRODH) and ∆1-pyrroline-5-carboxylate (P5C) dehydrogenase
(P5CDH/GSALDH) domains responsible for the first step of proline oxidization to
P5C and consecutively to glutamate. Substrate channeling have many beneficial
effects by increasing catalytic efficiency, reducing transition time and intermediate
toxicity, and preventing competing reactions in the cell. To further investigate
substrate channeling in enzymes, we examined the kinetics of PutA from
Sinorhizobium meliloti (SmPutA) and a few SmPutA variants, including tunnelblocking mutant SmPutA Asn999Tyr, monofunctional SmPutA Arg489Met and
SmPutA Cys844Ala as potential non-channeling control pairs. Intriguingly,
although the Asn999Tyr mutant locates in the middle of the tunnel, the GSALDH
activity is decreased by 10-fold. Furthermore, the mixture of both monofunctional
mutants showed channeling activity comparable to that of wildtype SmPutA. These
results suggest that the oligomerization state could contribute to channeling
thereby preventing leakage of the intermediate P5C between protomers of the
dimer, which has not been previously observed in other PutAs.

Introduction
Substrate channeling is defined as the direct transfer of an intermediate product
from one active site to another inside the enzyme without leaking of it to the bulk
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media1. Substrate channeling happens not only in multifunctional enzymes but
also among monofunctional enzymes that share metabolic intermediates. When a
series of related metabolic enzymes associate, they form a complex called a
metabolon, which allows substrate channeling to occur between enzymes of the
complex2. Substrate channeling has multiple cellular and enzymatic benefits. By
direct transfer of the intermediate, it facilitates the transfer process. At the same
time, the substrate concentration at the consecutive active sites is higher than the
bulk media and increases the catalytic velocity. Also, if the intermediate is toxic,
substrate channeling reduces its toxicity of the intermediate. The process also
prevents any competing reactions from taking place1.
Proline metabolism is an important pathway and involves many critical cellular
activities, including cellular bioenergetics, redox homeostasis, stress response,
osmoprotection, and bacterial pathogenesis3–8. Δ1-pyrroline-5-carboxylic acid
(P5C) is the first product of proline catabolism9. However, P5C is toxic to cells10,11.
Accordingly, substrate channeling was found in the bifunctional enzyme proline
utilization A (PutA), which possesses both proline dehydrogenase (PRODH) and
glutamate-gamma-semialdehyde dehydrogenase (GSALDH) activity12–15. The
bifunctional PutAs are typically found in Gram-negative bacteria9. In higher-level
organisms like plants and animals, the PRODH and GSALDH are expressed as
separate polypeptides9. However, there is evidence showing that the PRODH and
GSALDH can assemble together to form a complex that channels P5C between
the PRODH and GSALDH enzymes16.
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Figure 1. Domain structure, classification, and three representative oligomerization
states of PutAs. Figure adapted and edited from “Structure and characterization of
a class 3B proline utilization A: Ligand-induced dimerization and importance of the
C-terminal domain for catalysis,” by D. A. Korasick, et al., 2017, Journal of
Biological Chemistry, 292(3), 9652-9665. Copyright 2017 by The American Society
for Biochemistry and Molecular Biology, Inc. (A) Domain structure of type A, B, and
C PutA. (B) classification of PutAs. (C) 3 representative oligomerization states of
PutAs. Abbreviations: ALDHSF for aldehyde dehydrogenase super family,
GSALDH for glutamate-gamma-semialdehyde dehydrogenase, PRODH for
proline dehydrogenase, BjPutA, CfPutA, GsPutA, SmPutA for proline utilization A
from Bradyrhizobium japonicum, Corynebacterium freiburgense, Geobacter
sulfurreducens, and Salmonella typhimurium.

Even though there are studies of the channeling properties of PutAs from
Bradyrhizobium

japonicum15,

Corynebacterium

freiburgense17,

Geobacter

sulfurreducens14, and Salmonella typhimurium12, the architecture, oligomerization
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state, and quaternary structure of PutA varies between different species. In this
study, we are using the PutA from Sinorhizobium meliloti (SmPutA) as a model
protein for substrate channeling studies. SmPutA is a type1A PutA possessing
PRODH, GSALDH, and an additional aldehyde dehydrogenase superfamily
(ALDHSF) domain (Figure 1). SmPutA forms a homodimer with a large interface
(Figure 1C) and has a 40 Å tunnel that links the PRODH and GSALDH active sites.
A recent structure of SmPutA showed that in the middle of the channel, Asn999 is
positioned along the wall of the tunnel. Asn999 was thus mutated to Tyr in an
attempt to block the channel. Since P5C is non-enzymatically hydrolyzed to
glutamate-5-semialdehyde (GSAL) before being oxidized to glutamate at the
GSALDH active site, we hypothesized that the N999Y mutant will block the
P5C/GSAL intermediate.
To assess the impact of the Asn999Tyr mutant on substrate channeling, here
we purified and characterized the SmPutA N999Y mutant by steady-state and
stopped-flow kinetics. To aid our assessment of substrate channeling in SmPutA,
we also characterized separate SmPutA mutants R489M and C844A that are
anticipated to be devoid of PRODH and GSALDH activity, respectively. These
mutants enabled us to study substrate channeling using an equal mixture of
monofunctional SmPutAs (i.e., R489M and C844A) that are able to catalyze the
overall conversion of L-proline to L-glutamate without necessarily using a
channeling mechanism. Unexpectedly, the mixture of the R498M and C844A
monofunctional SmPutA mutants exhibited substrate channeling activity similar to
that of WT SmPutA.
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Material and Method
SmPutA R489M, C844A, and N999Y mutant constructs were purchased from
GenScript using pNIC28-BSA4 WT SmPutA as the template. All chemicals and
buffers were purchased from Fisher Scientific and Sigma-Aldrich, unless otherwise
noted. DL-P5C was synthesized according to the method of Williams and Frank
and stored in 1 M HCl at 4 oC18. P5C concentrations were determined by adding
o-aminobenzaldehyde (o-AB) and measuring the absorbance at 443 nm (ε443 nm =
2590 M-1 cm-1)18.
Purification of WT SmPutA and SmPutA variants
WT SmPutA, N999Y, R489M, and C844A SmPutA mutants were expressed in
Escherichia coli BL21(DE3) pLysS using the pNIC28 expression vector as
previously described with minor modifications19,20. A 5-mL overnight culture grown
in LB was used to inoculate a 2 L TB culture. BL21(DE3) cells were grown at 37
˚C until an OD600 of 0.8, for WT and N999Y SmPutA, the protein expression was
induced with 0.25 mM IPTG for 10 h at 18 ˚C. R489M and C844A SmPutA were
induced with 1 mM IPTG for 16 h at 16 ˚C. The cells for WT and N999Y SmPutA
purification were harvested and then resuspended (1:10 ratio of wet cell mass to
buffer volume) in 50 mM Tris buffer (pH 7.8) containing 300 mM NaCl, 5 mM
imidazole, 5% glycerol, five protease inhibitors (3 mM ε-amino-N-caproic acid, 0.3
mM phenylmethylsulfonyl fluoride, 1.2 µM leupeptin, 48 µM tosyl phenylalanyl
chloromethyl ketone, and 78 µM tosyllysine chloromethyl 47 ketone hydrochloride),
20 µM FAD and 0.2% Triton-100; for R489M and C844A purification, the 5 mM
IMD in the resuspension buffer was removed. Resuspended cells were lysed on
ice via sonication using a model 550 Sonic Dismembrator (Fisher Scientific) with
an amplitude power setting of 5 for a total of 5 min using a pulse sequence of 5 s
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on and 15 s off. Cell lysed material was centrifuged at 20,000 g using a JA 20 rotor
for 30 min and the supernatant was collected. The supernatant was passed
through a 0.22 µm filter before loading onto a HisPur Ni-NTA Superflow Agarose
(Thermo Fisher Scientific) packed in a borosilicate glass column. The flow-through
was loaded back onto the column again before washing to enhance protein binding
to the column and protein yield. Protein was eluted step-wise using binding buffer
with increasing imidazole concentrations (10 mM, 40 mM, and 300 mM). The
eluted SmPutA was collected in 2 mL fractions, and SDS-PAGE under reducing
conditions was used to determine the purity of the fractions. The selected fractions
were pooled and dialyzed at 4˚C against dialysis buffer (50 mM Tris, 150 mM NaCl,
0.5 mM EDTA, 0.5 mM tris(hydroxypropyl)phosphine (THPP), 10% glycerol, pH
7.8). The dialyzed protein was then concentrated in an Amicon stirred cell using a
30 kDa molecular weight cut-off ultrafiltration disc from MilliporeSigma. The
concentrated protein was flash-frozen in 500 µL aliquots and stored at -80 oC. The
N-terminal hexahistidine tag was retained in purified SmPutA. The concentration
of

PutA

was

determined

using

the

BCA

method

(Pierce)

and

spectrophotometrically using a molar extinction coefficient of 12700 M-1cm-1 at 451
nm21.
Steady-state PRODH and P5CDH kinetics
PRODH

activity

was

determined

by

using

DCPIP

(2,6-

dichlorophenolindophenol) as the electron acceptor29–31. In brief, 0.1 µM enzyme
was mixed with 75 µM DCPIP, 0.3 mM phenazine methosulfate (PMS), and proline
(0-600 mM) in 20 mM Tris-HCl, 10% glycerol (pH 7.5). KM and kcat values were
obtained by fitting the initial rates to the Michaelis-Menten equation using Prism32.
For GSALDH activity D,L-P5C stock was neutralized freshly with NaOH and used
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within 3 h after neutralization. Assay was performed similarly as previously
described33 by mixing SmPutA enzyme (0.5 µM) with 0.2 mM NAD+ and varied
concentrations of L-P5C (0 – 3000 µM) in 50 mM phosphate buffer (pH 7.5, 150
mM NaCl). The concentration of L-P5C is assumed to be 50% of the D,L-P5C
stock., GSALDH activity was monitored by tracking the formation of NADH (ε340 =
6.22 mM-1cm-1) 34. Assays were performed in technical triplicates.
Steady-state PRODH-GSALDH coupled activity assay
The PRODH-GSALDH coupled activity of SmPutA with L-proline was studied
as previously described14. The reactions contained 0.25 µM of SmPutA WT or
variants mixed with 0.2 mM CoQ1 as the electron acceptor, 0.2 mM NAD+, and 20
mM of L-proline in assay buffer (50 mM potassium phosphate, 25 mM NaCl, pH
7.5). The coupled activity was measured by monitoring NADH production at 340
nm (ε340 =6.22 mM-1 cm-1).
Single-turnover PRODH kinetics
All stopped-flow kinetic measurements were conducted with a Hi-Tech
Scientific SF-61DX2 stopped-flow instrument equipped with a photodiode array
detector at 23 oC as previously described14,19. Enzyme, buffer, and substrate
solutions were degassed using 12 cycles of vacuum and nitrogen. All substrate
solutions were made in 50 mM phosphate buffer (25 mM NaCl, pH 7.5). In addition,
100 µM protocatechuic acid (PCA) and 0.05 U/mL protocatechuate 3,4Dioxygenase (PCD) were included in the substrate solutions to scrub residual
oxygen22. SmPutA WT, N999Y, R489M, C844A or an equal molar mixture of
R489M and C844A were rapidly mixed by stopped-flow with an equal volume of
80 mM proline, 0.4 mM NAD+ (40 mM, 0.2 mM NAD+ after mixing). The reactions
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were monitored by multiwavelength absorption from 300-700 nm. The absorbance
over time was fitted to double exponential decay using Prism 9, and kobs was
reported.
Results and Discussion
Single-turnover kinetics of SmPutA variants
The kinetics of substrate channeling activity of WT SmPutA and the N999Y
mutant was tested by rapid reaction kinetics in which no electron acceptor is
included in the reaction, therefore only allowing one turnover of the enzyme. Figure
1A shows the kinetics of proline reduction of the FAD and subsequent formation
of NADH after a single turnover with WT SmPutA. The rate of FAD reduction
occurred faster (kobs = 0.349 s-1) than NADH formation (kobs = 0.0568 s-1). Proline
reduction of FAD for the SmPutA N999Y mutant (kobs = 0.441 s-1) was similar to
that of WT SmPutA whereas NADH production was significantly slower with a
linear velocity rate of 2.6*10-8 M s-1. Eventually after 100 sec, the amount of NADH
produced matched the amount of FAD reduced (Figure 1B).
Single-turnover kinetics of SmPutA R489M and C844A were also conducted.
For the R489M mutant, only limited FAD is observed to be reduced (Figure 1C),
consistent with a critical role for Arg489 in proline binding in the PRODH active site.
Because P5C formation is severely limited, the amount of NADH produced is very
low. For the SmPutA C844A mutant, proline reduction occurred within a time scale
(kobs = 0.426 s-1) similar to that of WT SmPutA (Figure 1D). In contrast to WT
SmPutA, however, no NADH formation was observed, confirming the essential role
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of Cys867 for GSALDH activity. Next, an equal mixture of SmPutA mutants R489M
and C867A were rapidly mixed with proline. Figure 1E shows FAD reduction
occurs quickly (kobs = 0.441 s-1) while NADH production occurs much more slowly
over 100 sec as observed for the N999Y mutant (Figure 1B).
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Figure 2. Single-turnover kinetics of SmPutA WT and mutant enzymes. All
reactions were initiated by rapidly mixing SmPutA with 40 mM Proline and 0.2 mM
NAD+. Shown are the average absorbance traces from three technical replicates
(± standard error) at 450 nm for FAD reduction (red circles) and 340 nm for NADH
formation (blue circles) for the reactions with (A) SmPutA WT (40 µM), (B) SmPutA
N999Y (8 µM), (C) SmPutA R489M (20 µM), (D) SmPutA C844A (20 µM), and (E)
an equal molar mixture of R489M and C844A (10 µM each, 20 µM total). All
concentrations of enzymes and substrates are after mixing.

Steady-state kinetics of SmPutA WT and variants

A

B

PRODH Activity

15

P5CDH activity

3

WT

WT

5

V/[E] (s-1)

V/[E] (s-1)

N999Y
10

2

1

N999Y
0

0

0

200

400

[L-Proline] (mM)

600

0

500

1000

1500

[L-P5C] (µM)

2000

2500

105
Figure 3. The PRODH and GSALDH activity of SmPutA WT (red circle) and N999Y
(blue circle) mutant. For PRODH activity, SmPutA WT or N999Y (0.1 µM) were
mixed with L-proline (0-200 mM) as the varied substrate, 0.3 mM PMS as the
electron acceptor, and 75 µM DCPIP as the reporter dye. For GSALDH activity,
0.5 µM SmPutA WT or N999Y was mixed with L-P5C (0-3 mM) as the varied
substrate, 0.2 mM NAD+ as the fixed substrate, and NADH formation was
monitored at 340 nm for 5 min. The data are fit to the Michaelis-Menten equation,
and the resulting kinetic parameters are reported in Table 1.
The steady-state kinetic parameters for PRODH and GSALDH were next
determined for SmPutA WT and the mutant N999Y. Figure 3A shows the
Michaelis-Menten plots for PRODH and GSALDH activity with the kinetic
parameters reported in Table 1. As expected, the N999Y mutant shows similar
PRODH activity to WT SmPutA with a kcat/KM of 140 M-1s-1 (Table 1). For the
GSALDH activity of the N999Y mutant, an over 10-fold decrease in kcat/KM (300 M1 -1

s ) is observed relative to WT SmPutA (Figure 3B and Table 1), consistent with

the single-turnover experiments showing a severe deficiency in NADH formation.
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Figure 4. SmPutA R489M PRODH activity (A) and SmPutA C844A P5CDH activity (B) in
comparison with WT SmPutA (red circle). The PRODH and P5CDH were conducted as
earlier described.

Next, we characterized the steady-state kinetics of PRODH and GSALDH
activity in the SmPutA monofunctional variants R489M and C867A. Consistent
with single-turnover results, SmPutA R489M mutant lacked PRODH activity
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(Figure 4A) but exhibited GSALDH activity (Figure 4B) that was only 2-fold lower
(kcat/KM = 1900 M-1s-1) than SmPutA WT (Table 1). The lower kcat/KM value arises
from a 2.5-fold higher KM for L-P5C in the SmPutA R489M mutant. Conversely,
SmPutA C867A mutant showed PRODH activity (kcat/KM = 70 M-1s-1) (Figure 4A)
that was similar to SmPutA WT but was devoid of GSALDH activity (Figure 4B and
Table 1).
Table 1 Kinetic parameters of SmPutA variants
Active site

PRODH

GSALDH

Enzyme

kcat (s-1)

KM(P5C) (mM)

kcat/KM (M-1s-1)

WT

11.8 ± 0.79

116 ± 25

101 ± 29

N999Y

11.0 ± 0.56

81 ±13

134 ± 29

R489M

N/A*

N/A*

0.48

C844A

17 ± 2.2

240 ± 69

69 ± 29

WT

3.7 ± 0.42

1.06 ± 0.26

3700 ± 1300

N999Y

N/A*

N/A*

300

R489M

5.0 ± 0.36

2.6 ± 0.33

1900 ± 360

C844A

0.084 ± 0.014

3.7 ± 1.1

23 ± 11

*Limited by the L-P5C concentration, the L-P5C concentration used in the kinetic assay is
insufficient to estimate KM and kcat, thus only the kcat/KM can be obtained.

After characterizing the individual catalytic activity of all three SmPutA variants,
we proceeded to study substrate channeling activity. The SmPutA N999Y mutant
shows no channeling activity which is likely caused by low GSALDH activity (Figure
5). Following the reaction for up to 60 min with SmPutA N999Y also did not
generate NADH (data not shown) demonstrating a complete block in substrate
channeling. Both the monofunctional R489M and C867A mutants, show no
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channeling activity as expected due to the lack of either PRODH or GSALDH
activity (Figure 5). In the reaction mixture containing both monofunctional SmPutA
variants, however, NADH formation is observed and appears to mimic NADH
production observed with SmPutA WT (Figure 5). By extrapolating the linear
portion of NADH formation to the x-axis, no obvious lag time was observed for the
PRODH-GSALDH coupled activity in assays with SmPutA WT and SmPutA mixed
variants.
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Figure 5. Substrate channeling activity of SmPutA WT and variants. SmPutA
enzymes (0.5 µM each) were mixed with 40 mM L-proline and 0.2 mM NAD+ and
the absorbance at 340 nm was recorded for 20 min. Shown are the reaction traces
for SmPutA WT (blue), N999Y variant (purple), R489M variant (red), C844A
(green), and an equal molar mixture (0.5 µM each, 1 µM total) of the R489M and
C844A variants.
Because the SmPutA mixed variants exhibited PRODH-GSALDH activity that
was similar to that of SmPutA WT, we estimated the amount of P5C leaked into
bulk solvent during the substrate channeling assays. In these assays, the amount
of NADH formed is monitored in the absence and presence of the P5C trapping
reagent, o-AB. Figure 6 shows o-AB decreases NADH formation to the same
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extent in both SmPutA WT and the mixed variants. These results suggest the
availability of the P5C intermediate to the o-AB trapping agent is not increased in
the mixed variant system.
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Figure 6. NADH formation in the presence of a chemical trapping reagent. Coupled
PRODH-GSALDH activity assays were performed with SmPutA WT (0.5 µM) and
an equal molar mixture of R489M and C844A (0.5 µM each, 1 µM total). SmPutA
enzymes were added to assay solutions containing 40 mM L-proline and 0.2 mM
NAD+ with and without o-AB (4 mM). Shown are the absorbance traces at 340 nm
for SmPutA (red) and the mixed variants (blue) in the absence (closed symbols)
and presence (open symbols) of o-AB. The lower NADH formation observed in the
presence of o-AB indicates trapping of the P5C intermediate.
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Discussion
Asn999

Figure 7. Structure of SmPutA. Figure adapted and edited from “Structure and
characterization of a class 3B proline utilization A: Ligand-induced dimerization
and importance of the C-terminal domain for catalysis,” by D. A. Korasick, et al.,
2017, Journal of Biological Chemistry, 292(3), 9652-9665. Copyright 2017 by The
American Society for Biochemistry and Molecular Biology, Inc.
Asn999 is located in the middle of the main tunnel (see Figure 6). Thus,
mutation of Asn999 to Tyr is anticipated to generate a significant effect on
substrate channeling in SmPutA. Indeed, this was the case as observed by steadystate and single-turnover kinetic studies of the SmPutA N999Y mutant. The
PRODH activity of SmPutA N999Y is comparable to that of SmPutA WT but the
GSALDH and substrate channeling activity was severely diminished. Although
NADH formation is observed with SmPutA N999Y under single-turnover conditions,
the rate of NADH production is best fit by linear regression indicating a significant
delay in the transfer of P5C to the GSALDH active site, either partially through the
tunnel or via the bulk solvent (Figure 2). Curiously, the GSALDH activity with
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exogenous P5C is more than 10-fold lower than SmPutA WT. This result suggests
that exogenous P5C enters the GSALDH active site via the tunnel. Alternatively,
the N999Y mutation changes the conformation of the GSALDH active site that
impedes P5C binding, thus leading to a higher KM, a value for which we were not
able to estimate. X-ray crystal structure of SmPutA in complex with P5C/GSAL
could provide insights into how the substrate accesses the GSALDH active site. It
will also be important to obtain crystal structures of the N999Y mutant to confirm
blocking of the tunnel and evaluate whether the N999Y mutation causes changes
in the GSALDH active site that would result in lower activity.
An unexpected finding from this work was that the equal molar mixture of the
monofunctional SmPutA mutants R489M and C844A exhibited PRODH-GSALDH
coupled activity similar to that of SmPutA WT (Figure 5). In previous studies of
other PutAs, such as PutA from Bradyrhizobium japonicum and E. coli, the mixed
variants displayed a long lag time (~ 8 min) in coupled PRODH-GSALDH assays
prior to NADH formation whereas the corresponding WT PutAs showed no
significant lag in NADH production. What is more, the amount of P5C trapped by
o-AB in the bulk solvent during coupled PRODH-GSALDH assays is also similar
between the SmPutA WT and the mixed variants (Figure 6). Why there is a
discrepancy between the mixed variants of SmPutA and previously studied PutAs
is not apparent, but it may involve differences in the oligomeric structures of PutAs.
As shown in Figure 1, the oligomeric state of PutAs is quite different between
bacterial species. Unlike other PutAs, SmPutA forms a dimeric structure that
involves an extensive amount of surface area that results in placing the PRODH

111
and GSALDH active sites from different protomers in close proximity to each other.
This does not occur in other PutAs such as PutA from Geobacter sulfurreducens
(GsPutA). Thus, SmPutA mixed variants may resemble substrate channeling
behavior similar to SmPutA WT due to the proximity of the functional active sites
in the dimer. Additional studies will be required to test this hypothesis such as
determining the oligomeric states of SmPutA WT and the mixed variants by
sedimentation velocity to confirm they form a dimer under the same conditions
used for our kinetic assays. Structures of the mixed variant dimer would also
confirm the proximity of the two functional active sites. Showing that both the
tunneling and proximity mechanisms are utilized to protect the P5C/GSAL
intermediate in SmPutA during catalysis may have important implications for
proline catabolic enzymes in other organisms. The transfer of the P5C/GSAL
intermediate between monofunctional enzymes (e.g., human PRODH and
GSALDH) may rely solely on the proximity of the two active sites in PRODHGSALDH metabolic complexes.
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Chapter 5. Summary
Proline metabolism lies in the center of many important cellular pathways1–6.
The first step of proline metabolism is dependent on proline dehydrogenase
(PRODH). In bacteria, the PRODH is transcribed together with glutamate-gammasemialdehyde dehydrogenase (GSALDH/P5CDH) called PutA7. Chapter 1
provided a broad introduction to proline metabolism, related enzymes, and
metabolic disorders, as well as enzyme allostery and promiscuity. There is an
additional DNA-binding domain at the N-terminus of PRODH-PutA in some Gramnegative bacteria, such as Escherichia coli; thus allowing the PutA cellular
localization to switch from DNA binding to membrane association by sensing
cellular proline level8,9. The PutA uses FAD and NAD+ as cofactors connecting
cellular redox balance to its function. Therefore, the trifunctional PutAs are great
models for studying functional switching of proteins.
Chapter 2 characterized an L1 linker-truncated E. coli PutA mutant (∆50-85
EcPutA) to elucidate the details of the role of the linker in the functional change of
PutA. Creation of linkers of different lengths or amino acid substitution will be
needed to further characterize the linker's role. Pyruvate dehydrogenase/oxidase
(Pox) is an enzyme that shares a few similarities with EcPutA. Pox is a cytosolic
enzyme that uses FAD as a cofactor and shifts to the peripheral of the membrane
upon flavin reduction. A linker region facilitates a conformational change in Pox
upon reduction of the FAD. Linkers provide conformational flexibility necessary for
multi-domain proteins. A better understanding of the linker function in PutA may
benefit the field of protein design.
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The disruption of proline metabolic regulation is related to many human
diseases, including certain types of cancer10–16. Thus, the discovery of small
molecules that activate or inhibit proline metabolic enzymes may have potential
clinical benefits. T2C and T4C are natural proline analogs and are proposed to be
oxidized by PRODH but no kinetic characterization has been reported. Chapter 3
studied the single turn-over and steady-state kinetics of thiol-containing natural
proline analogs T2C and T4C using SmPutA as a model. Future experiments
characterizing the kinetics of human PRODH will address the pathophysiological
relevance of this discovery. Additionally, cell biology studies will provide more
results relevant to clinical application, including suppression or overexpression of
PRODH when supplementing T2C and T4C or other proline analogs.
There is evidence of channeling the intermediate P5C from the PRODH active
site directly to the GSALDH site within PutA. Therefore, the bifunctionality of it
becomes an interesting and important model for channeling studies of enzymes
(Chapter 4). Chapter 4 characterized the tunnel blocking mutant SmPutA N999Y,
a bifunctional enzyme, to further elucidate the substrate channeling. The results
suggest that the N999Y mutant at least partially blocked the tunnel in the enzyme.
And the channeling event between the two protomers of the SmPutA dimer is first
time observed in PutAs. More studies need to be done to gain insights into the
channeling mechanism of the SmPutA, to be more specific, Kirsch assay will
provide solid evidence of dimer-dependent channeling upon titrating nonfunctional SmPutA into WT SmPutA.
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